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 Schizophrenia is a severe psychiatric illness characterized by positive, negative, 
and cognitive symptoms.  The observation that the onset of clinical symptoms is often in 
early adulthood has led to the neurodevelopmental hypothesis which posits that 
schizophrenia results from altered developmental processes beginning long before onset 
of clinical symptoms.  The present thesis aimed to evaluate two neurodevelopmental 
animal models of schizophrenia-like behaviours.  Chapter one explored the 
epidemiological association between maternal infection and schizophrenia by using a 
well-validated animal model of maternal viral infection.  Pregnant Wistar rats were 
injected with the viral mimic polyriboinosinic-polyribocytidilic acid (poly I:C) and 
juvenile and adult offspring were assessed for altered novel object preference (NOP), 
sensitivity to the locomotor-activating effects of amphetamine, and deficits in 
preattentive sensorimotor gating mechanisms.  Our findings suggest that prenatal poly I:C 
did not result in the expected behavioural deficits in adulthood.  Our findings challenge 
the robustness of the poly I:C model.  In chapter two, we examined behavioural and 
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neurochemical consequences of prenatal blockade of the glutamate receptor, N-methyl-
D-aspartate (NMDA), in juvenile and adult offspring.  Pregnant Long-Evans rats received 
daily injections of saline or the NMDA receptor antagonist, MK-801.  Offspring were 
exposed to a battery of behavioural tasks.  The most dramatic of our findings were the 
altered NOP, hyposensitivity to MK-801 challenges, and deficits in cognitive flexibility 
observed in the adult male offspring.  Although sometimes contrary to our hypotheses, 
the overall pattern of our results suggest that prenatal NMDA receptor blockade disrupted 
normal brain development and induced important behavioural deficits in adulthood. 
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 Schizophrenia is a psychiatric illness affecting up to 1% of the population 
(Kulhara & Chakrabarti, 2001; Torrey, 1987).  This uniquely human condition has been 
ranked, in economic terms, the seventh most costly medical illness to modern society 
(Freedman, 2003) with expenditures reaching approximately $6.85 billion a year in 
Canada alone (Goeree, O'Brien, & Blackhouse, 2004).  Of this total cost estimate, 
approximately 70% is accounted for by productivity losses associated with morbidity in 
schizophrenia.  Indeed, schizophrenia is characterized by a heterogeneous set of 
symptoms that make it challenging for those struggling with the disorder to function 
within societal norms.  The clinical onset of these symptoms most commonly occurs 
during the second or third decade of life and has an average age of diagnosis in males 
four years earlier than in females (Riecher-Rossler & Hafner, 2000).  For research 
purposes, these symptoms are often grouped into three main categories: positive 
symptoms (e.g. hallucinations and delusions), negative symptoms (e.g. blunted speech, 
anhedonia, avolition, etc.), and cognitive symptoms (e.g. impaired working memory, 
poor cognitive flexibility, etc.).  There is yet to be a single theory that fully explains the 
complex pattern of positive, negative, and cognitive impairment in schizophrenia.  
Understanding the underlying mechanisms of this disease will shed light into its etiology 
and will help develop better treatment that will more effectively target the full 
symptomatology.     
Symptoms 
 Positive symptoms generally reflect an excess of normal functions (Stahl, 2008).  
Delusions are one type of positive symptoms and refer to misinterpretation of perceptions 
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or experiences.  The content of delusions may follow a variety of themes such as 
referential (i.e. believing that something refers to oneself), somatic, religious, grandiose, 
or the most common, persecutory.  Hallucinations are another type of positive symptoms 
and can occur in any sensory modality (e.g. visual, olfactory, gustatory, and tactile) 
though auditory appears to be the most common.  Other symptoms grouped under the 
positive dimension include disorganized speech and/or behaviour, catatonic behaviour, 
and agitation.  Positive symptoms of schizophrenia are often emphasized as they can be 
dramatic and surprising.  Despite their dramatic nature however, positive symptoms are 
the symptoms most effectively treated by antipsychotic medication (Stahl, 2008).   
 Negative symptoms are commonly considered a reduction in normal functions 
(Stahl, 2008).  Without referring to these concepts directly, Emil Kraepelin (1856-1926) 
was the first to provide a thorough description of what is currently viewed as the negative 
symptoms of schizophrenia, observing what he called "a core deficit in emotional 
experience" (Jablensky, 2010).  This deficit is associated with the absence of feelings that 
is responsible for blunted affect, as well as the absence of pleasure from activities, the 
absence of a desire for activity, and an overall lack of motivation (Azorin, Belzeaux, & 
Adida, 2014).   
 Nearly a century later, the Measurement and Treatment Research to Improve 
Cognition in Schizophrenia (MATRICS) consensus panel proposed a two-factor model to 
account for negative symptoms which closely resembles Krapelin's original description: 
1) blunted affect-poverty of speech and 2) anhedonia-asociality-avolition (Kirkpatrick & 
Fischer, 2006).  Anhedonia refers to the reduced ability to experience pleasure (e.g. the 
patient sees previous hobbies or interests as unpleasurable).  Ascoiality is a reduced 
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social drive and interaction (e.g. little sexual interest, little interest in spending time with 
friends).  Avolition refers to a general reduction in desire or motivation (e.g. reduced 
ability to undertake everyday tasks such as personal hygiene) (Kirkpatrick & Fischer, 
2006).  The validity of these two subgroups is supported by evidence that distinct groups 
of patients demonstrating these characteristics are identifiable and clinically 
distinguishable.  For instance, compared with patients from the blunted affect-poverty of 
speech subgroup, patients in the anhedonia-asociality-avolition subgroup are more likely 
to have a family history of psychiatric illness, less likely to be employed, more likely to 
experience poorer premorbid social adjustment, and more likely to experience a gradual 
onset of psychosis (Strauss et al., 2013).   
 Negative symptoms in schizophrenia are associated with long periods of 
hospitalization and poor social functioning (Herbener & Harrow, 2004).  Although they 
may not appear to be as dramatic as the positive symptoms, negative symptoms 
ultimately determine whether a patient can function well within societal norms.  
Interestingly, although negative and positive symptoms appear to follow independent 
courses over time, the negative symptoms are associated with cognitive symptoms 
(Eaton, Thara, Federman, Melton, & Liang, 1995; van Os & Kapur, 2009).   
 Eugen Bleuler, who coined the term "schizophrenia" in the early 1900s, argued 
for impaired cognition rather than delusions and hallucinations as the fundamental 
dysfunction in the illness (Heinrichs, 2005).  Although previous research on 
schizophrenia has often addressed the positive symptoms, the cognitive symptoms have 
been described as being the most ubiquitous features of schizophrenia (Bowie & Harvey, 
2005) and serving as the prominent determinants of functional disability and poor 
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prognosis that is observed in a majority of chronically ill patients with schizophrenia 
(Green, Kern, Braff, & Mintz, 2000).  In addition, although antipsychotic treatment has 
been helpful in relieving positive symptoms and attenuating, to a lesser extent, negative 
symptoms, cognitive symptoms of schizophrenia remain largely resistant to currently 
available medications (P.  D.  Harvey & Keefe, 2001; Keefe, 2007).   
 Executive functions (e.g. attention, cognitive flexibility) and memory (visual and 
spatial), both of which are associated with the frontal and medial temporal regions of the 
brain, are thought to be the cognitive functions most severely affected in 
schizophrenia(Danielyan & Nasrallah, 2009).  Attentional deficits are commonly 
described as an inability to filter out irrelevant stimuli.  There are indications that 
attentional deficits may constitute a behavioural marker for predisposition to 
schizophrenia in high risk individuals (e.g. family history of schizophrenia) (Erlenmeyer-
Kimling et al., 2000).  Sensorimotor gating is a feature of pre-attentive cognitive 
processing that is consistently reported to be impaired in schizophrenia patients (L.  Li, 
Du, Li, Wu, & Wu, 2009; Swerdlow, Geyer, & Braff, 2001).  Its impairments are 
considered to be an indication of a failure of inhibitory filtering mechanisms that can lead 
to sensory overload (Geyer, 2006a, 2006b).  The most robust correlates of the deficits in 
sensorimotor gating are abnormalities in distractibility and thought disorder (Geyer, 
2006b).   
 One important operational measure of sensorimotor gating is pre-pulse inhibition 
(PPI), which has been shown to be impaired in schizophrenia (L.  Li et al., 2009).  PPI 
refers to the normal reduction of the amplitude of the startle reflex in response to an 
intense startling stimulus (the pulse) when this is shortly preceded by a weaker, non-
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startling sensory stimulus (the pre-pulse) (L.  Li et al., 2009).  Another operational 
measure that is often used to study the neural substrates of complex associative deficits in 
schizophrenia is latent inhibition.  Latent inhibition refers to the instances when an 
individual learns to ignore a repetitive, trivial stimulus that does not predict an important 
event.  However, when this stimulus is later given meaning as a predictor of an important 
event, the person must overcome the learned ignore response before new learning can 
occur (Swerdlow, Braff, Hartston, Perry, & Geyer, 1996).  Patients with schizophrenia 
have been shown to exhibit a deficit in latent inhibition which is reflected as faster 
learning of the second association in patients with schizophrenia resulting from the 
inability to gate or suppress the cognitive response to an irrelevant stimulus (Swerdlow et 
al., 1996).   
 Impairment in cognitive flexibility is amongst the most reliable deficit observed 
in schizophrenia (Green & Nuechterlein, 2004).  Cognitive flexibility refers to the ability 
to flexibly change perspectives and to adjust to new demands, rules, or priorities 
(Diamond, 2013).  This is the ability that allows us, for instance, to come up with new 
ways of tackling problems when previous attempts have failed.  It also allows us to adjust 
our behaviour to meet new demands or take advantage of serendipitous events.  One of 
the most widely used paradigms to assess cognitive flexibility in humans is a set-shifting 
task known as the Wisconsin Card Sorting Test (WCST) in which the person is asked to 
match a given choice card with four key cards based on one of the three stimulus 
dimensions (colour, shape of polygons, number of polygons) (Berg, 1948).  After a 
certain criterion has been reached, the person must discard the old sorting rule and attend 
to a new one (e.g. switching from a colour-based sorting to shape-based sorting).  
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Patients with schizophrenia display great difficulty in such tasks that require them to shift 
between different rules or strategies (Green & Nuechterlein, 2004) .  These impairments 
appear to be due in part to an inability to shift attentional set from one stimulus 
dimension to another (Floresco, Zhang, & Enomoto, 2009).  More specifically, patient's 
set-shifting deficit is thought to represent a failure to shift from previously rewarded 
behaviour in response to negative feedback.   These impairments have long been 
attributed to perturbation in frontal lobe functioning (Floresco et al., 2009). 
 Although Kraepelin and Bleuler both argued that memory functions were 
relatively preserved in schizophrenia, many studies have since demonstrated that patients 
with schizophrenia do in fact perform poorly on a wide range of memory tasks 
(Jablensky, 2010).  Recognition memory, the evocation of relevant multimodal memories 
that enable the experience of familiarity with a given stimulus (Kim et al., 1999), has 
been shown to be particularly disrupted in schizophrenia.  More specifically, 
schizophrenia patients show deficits in verbal and facial recognition.  Amongst the 
various forms of visual stimuli, faces are especially crucial to humans as their recognition 
is essential to human social life (Kim et al., 1999).  Thus, although such deficits are often 
viewed as cognitive in nature, they may also overlap with negative symptoms such as 
asociality. 
Neurotransmission in schizophrenia 
 Alterations in several neurotransmitter systems have been implicated in the 
pathophysiology of schizophrenia.  There are consistent pharmacological and functional 
data for the involvement of dopamine (DA) and glutamate, giving rise to two main 
hypotheses that link disruptions of these systems to the neuropathology of schizophrenia.  
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It should be noted that there is also ample evidence for the involvement of gamma-
Aminobutyric acid (GABA), cholinergic, and opioid systems in schizophrenia, but the 
focus of the present thesis will be on the DA and glutamate systems.   
 The dopamine hypothesis.  One neurochemical hypothesis which has shown 
remarkable tenacity is the DA hypothesis.  DA is a neurotransmitter with highly 
diversified functions in the brain.  As seen in Figure 1, the mesocorticolimbic DA system 
consists of neurons with cell bodies located in the ventral tegmental area (VTA) 
projecting to the prefrontal cortex (PFC; mesocortical) and nucleus accumbens (NAcc; 
mesolimbic) (Stahl, 2008).  The classical DA hypothesis of schizophrenia posited that 
hyperactivity of the DA system was responsible for the symptoms observed in 
schizophrenia (Carlsson & Lindqvist, 1963).  This hypothesis has since been expanded to 
include the idea that it is the hyperactivity of the mesolimbic DA system that contributes 
to the positive symptoms in schizophrenia while the hypoactivity of the mesocortical DA 
system contributes to the cognitive symptoms (Davis, Kahn, Ko, & Davidson, 1991).   
 The DA hypothesis originally derived from the observation that the antipsychotics 
used to treat the positive symptoms of schizophrenia act primarily as DA receptor 
antagonists (Seeman, Chau-Wong, Tedesco, & Wong, 1975; Seeman & Lee, 1975).  In 
addition, high doses of stimulant drugs such as cocaine in healthy individuals can evoke 
transient psychotic states that resemble positive symptoms of schizophrenia (Lieberman, 
Kane, & Alvir, 1987).  Furthermore, pharmacological studies have demonstrated that 
exposure to amphetamine (AMPH), a stimulant drug that increases extracellular levels of 
DA in the striatal regions via release and reverse transport, can exacerbate positive 




Figure 1.  Sagittal view of the human (left) and rat (right) brains, showing the 
mesolimbic and mesocortical DA pathways, which originate in the ventral tegmental area 
(VTA) and send ascending projections to the nucleus accumbens (NAcc) and medial 
















individuals (Lieberman et al., 1987).  More support for the DA hypothesis of 
schizophrenia comes from imaging studies that have demonstrated  marked elevations of 
AMPH-induced striatal DA release in non-medicated schizophrenia patients compared to 
healthy volunteers (Abi-Dargham et al., 2000; Laruelle et al., 2000; Laruelle et al., 1996).  
In addition, analysis of post-mortem brains of patients with schizophrenia have shown 
increased striatal density of DA D2 receptors in comparison to healthy controls (Seeman 
et al., 1987).  Due to the observation that antipsychotic treatment up-regulate D2 
receptors (Soares & Innis, 1999), it is often argued that this finding is a consequence of 
pharmacotherapy.  However, increased D2 levels have also been found in non-medicated 
patients (Toru et al., 1988).   
 Hyperactive mesolimbic DA function in schizophrenia is commonly associated 
with a hypofunctioning mesocortical DA system.  Indeed, patients with schizophrenia 
have been shown to struggle with cognitive tasks that are PFC-dependent such as 
executive functions and memory.   In fact, a study combining imaging techniques and the 
WCST (associated with PFC functioning) showed that patients had less WCST-related 
activation in the PFC and that the degree of abnormal activation in the PFC served as a 
predictor of the magnitude of the mesolimbic DA hyperactivity (Meyer-Lindenberg et al., 
2002).  Furthermore, decreased DA innervation to the PFC has also been observed in 
patients with schizophrenia (Abi-Dargham et al., 2000).   
 The glutamate hypothesis.  Glutamate is an amino acid serving as the major 
excitatory neurotransmitter in the brain and is thought to be dysfunctional in 
schizophrenia.  The postsynaptic effects of glutamate are mediated by three families of 
gated ion channels: the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), 
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N-methyl-D-aspartate (NMDA) and kainate (Coyle, 2006; Platt, 2007).  There is 
cumulating evidence that the glutamate dysfunction observed in schizophrenia is 
mediated by NMDA receptor hypofunction (Duncan, Sheitman, & Lieberman, 1999).   
As was the case for the role of DA in schizophrenia, the role of NMDA receptors 
was determined as a result of pharmacological discovery.  Glutamate was first considered 
as a potential player in schizophrenia in the 1950s when phencyclidine (PCP), an NMDA 
receptor antagonist, was observed to induce a schizophrenia-like psychotic state in 
humans (Gordon, 2010; Kantrowitz & Javitt, 2010; Luby, Cohen, Rosenbaum, Gottlieb, 
& Kelley, 1959).  The link to NMDA receptors, however, was not suspected until the 
1980s when researchers provided evidence implicating that blockade of the NMDA 
receptor was the primary mechanism by which PCP produced its effects (D.  Lodge, 
Anis, & Burton, 1982).  Subsequent research demonstrated that ketamine and MK-801, 
NMDA receptor antagonists, also induced psychosis and cognitive deficits closely 
resembling symptoms of schizophrenia (Coyle, 2006).  Furthermore, individuals with 
schizophrenia show greater sensitivity to the psychomimetic effects of these drugs at 
doses that have little or no effect in healthy individuals (Javitt & Zukin, 1991).  
Corroborating the role of glutamate dysfunction in schizophrenia, and more specifically 
NMDA receptor hypofunction, are findings suggesting that symptoms, particularly the 
negative symptoms, can be relieved with NMDA receptor modulators such as D-serine, 
glycine and sarcosine which serve to increase NMDA receptor function (Ross, Margolis, 
Reading, Pletnikov, & Coyle, 2006).  In addition, imaging studies have provided in vivo 
evidence for reduced NMDA receptor binding in the hippocampus of non-medicated 
patients with schizophrenia compared to healthy controls (Bressan & Pilowsky, 2000).  
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This evidence suggests that hypofunction of the NMDA receptor, possibly on critical 
GABA interneurons, may contribute to the pathophysiology of schizophrenia (Coyle, 
2006).   
Given the previously mentioned observation that current antipsychotic 
medications acting primarily through DA D2 receptor blockade fail to relieve all 
symptoms of schizophrenia, researchers have concluded that these symptoms likely 
involve neurotransmitter systems other than DA, such as glutamate and GABA.  
However, this view and the DA hypothesis should not be considered as mutually 
exclusive.  Rather, results point to important interactions between DA receptors and 
NMDA receptors in critical brain regions such as the hippocampus and between 
glutamatetamatergic afferents and subcoritcal dopaminergic nuclei (Adler, Freedman, 
Ross, Olincy, & Waldo, 1999; Breier et al., 1998).  Thus, schizophrenia is now believed 
to involve at least both glutamatetamatergic and dopaminergic dysfunction.  One of the 
greatest challenges for schizophrenia research at present is to understand the etiology of 
such dysfunctions. 
Neurodevelopmental Hypothesis 
 Many hypotheses have been put forth to explain the etiology of schizophrenia.  Of 
these, one the most widely acknowledged is the neurodevelopmental hypothesis, the view 
that schizophrenia is the outcome of an aberration in neurodevelopmental processes 
beginning long before onset of clinical symptoms (Fatemi & Folsom, 2009).  Critical 
processes that are altered include neurogenesis, cell migration, and neuronal connectivity 
(Ehninger & Kempermann, 2008; Fatemi & Folsom, 2009).   
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 There are several independent lines of evidence that support the conceptualization 
of schizophrenia as a neurodevelopmental psychiatric disease.  For instance, there is no 
evidence of gross physical damage or signs of progressive neurodegernation and/or 
ongoing brain inflammatory processes in patients with schizophrenia (Rapoport, 
Addington, & Frangou, 2005; Weinberger, 1987).  In addition, many indicators of 
congenital anomalies, such as the presence of low-set ears, epicanthal eye folds, and wide 
spaces between the first and second toes, are present in patients with schizophrenia and 
indicative of first trimester anomalies (Danielyan & Nasrallah, 2009).  In addition to 
physical manifestations, pre-schizophrenic children present behavioural alterations before 
the clinical onset of psychosis.  These premorbid signs include 'soft' neurological 
symptoms such as slight posturing of hands and transient choreoathetoid movements.  In 
addition, delays in motor and speech development, poor peer relationships, social 
isolation, social anxiety, and lower cognitive abilities have been reported to occur more 
frequently in high-risk children with a schizophrenic parent (Danielyan & Nasrallah, 
2009).  Importantly, these alterations are present before the clinical onset of 
schizophrenia and before pharmacological treatment, indicating that they are not the 
result of progressive degenerative processes or pharmacotherapy (Danielyan & Nasrallah, 
2009).  Another important observation supporting the neurodevelopmental hypothesis is 
the observation that individuals who go on to develop schizophrenia are more likely to 
have experienced pre- or peri-natal adverse events compared to healthy individuals 
(Fatemi & Folsom, 2009; Weinberger, 1987).   
Interaction of genetic and environmental factors 
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According to the neurodevelopmental hypothesis, the etiology of schizophrenia 
involves both genetic and environmental factors resulting in disruption of developmental 
processes occurring as early on as in prenatal development (Fatemi & Folsom, 2009).  
The genetic component of the gene-environment interaction is supported by a large body 
of evidence (Danielyan & Nasrallah, 2009; Sawa, Pletnikov, & Kamiya, 2004; Tsuang, 
2001).  According to twin and adoption studies, more than half of the vulnerability for 
schizophrenia is of genetic origin (Tsuang, 2001).  Although the risk of schizophrenia in 
the general population is only of approximately 1%, this risk increases substantially in 
relatives of individuals with the disorder.  For instance, monozygotic twins (i.e.  sharing 
100% of DNA) have a risk of 40-50% when one twin has schizophrenia, whereas this risk 
decreases to 9% for a dizygotic twin or sibling of an individual with schizophrenia (i.e.  
sharing approximately 50% of DNA) (Sawa et al., 2004; Tsuang, 2001).  Despite the 
large contribution of genetic factors to schizophrenia, its genetic constituent is considered 
to be composed of multiples genes with relatively low individual risk factors.  For 
instance, up to 50 candidate genes that may play a role in explaining individual 
differences in vulnerability or resilience to the development of schizophrenia have been 
identified (Shirts & Nimgaonkar, 2004).  Remarkably, these genes have been shown to 
play a role in brain development, thereby supporting the role of alterations in 
neurodevelopment in the etiology of schizophrenia (Harrison & Weinberger, 2005).  
Nonetheless, the less than perfect monozygotic twin concordance rate for schizophrenia 
(approximately 50%) indicates the presence of non-genetic contributing factors (Sawa et 
al., 2004; Tsuang, 2001).   
 14 
 
Several environmental risk factors for schizophrenia have been documented.  
Prenatal events such as maternal stress, famine, substance abuse, infection, or exposure to 
teratogens during pregnancy have been associated with a higher risk for schizophrenia in 
adult offspring (Caspi & Moffitt, 2006).  Other environmental factors include low birth 
weight and birth complications as well as postnatal events such as early postnatal trauma, 
parental negligence during infancy, childhood abuse, premature parental loss, family 
conflict and violence, substance abuse during adolescence, and head injury (Arndt, 
Stodgell, & Rodier, 2005; Caspi & Moffitt, 2006).  It is, however, important to keep in 
mind that most of the mentioned environmental risk factors constitute a nonspecific risk 
for many disorders.  For instance, birth complications have been found to be linked to 
ADHD, mental retardation, and autism spectrum disorders in addition to schizophrenia 
(Caspi & Moffitt, 2006).  Thus, such factors cannot be considered predictive of a 
particular neurodvelopmental psychiatric disease.  Another important consideration is 
that environmental risk factors are regarded as contributory as exposure to them does not 
always result in psychiatric illness.   
Nonetheless, the evidence from genetic studies and epidemiological research 
strongly suggests that a gene-environment interaction is involved in the etiology of 
schizophrenia.  The gene-environment interaction implies that in any given population, 
individual genetic predisposition is directly responsible for the vulnerability to the 
environmental risk factors of schizophrenia.  Human studies have been useful in 
furthering our understanding of the effects of this interaction on the developing brain.  It 
is, however, impossible to experimentally assess the relative magnitude of the inherited 
and environmental contributors without the use of animal models (Boksa, 2004).   
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Neurodevelopmental animal models of schizophrenia 
 The role of dopamine and glutamate in schizophrenia that is presumed from 
human studies has received a substantial amount of support from research with animal 
models (Boksa, 2004, 2010).  In line with what has been observed in humans, acute and 
repeated treatment with dopamine agonists such as cocaine and amphetamine in adult 
rodents induces psychomimetic responses such as hyperactivity, impairments in 
sensorimotor gating, working memory, object recognition, and set-shifting.  Research 
aimed at elucidating the role of glutamate has demonstrated that acute and repeated 
exposure to NMDA receptor antagonists such as PCP, ketamine, and MK-801 in adult 
rats induces hyperlocomotion, PPI deficits, social deficits, and memory and set-shifting 
deficits (Neill et al., 2010; Neill, Harte, Haddad, Lydall, & Dwyer, 2014).  Results from 
such animal models have been invaluable in providing further support to the DA and 
glutamate hypotheses of schizophrenia and in elucidating how these two systems interact 
with each other.  However, these models fail to capture the neurodvelopmental nature of 
schizophrenia.  Neurodevelopmental animal models are based on experimentally induced 
disruption of brain development that becomes evident in an adult animal in the form of 
altered neurochemistry and aberrant behaviour and test whether the effects of early brain 
damage could remain inconspicuous until after a considerable delay as appears to be the 
case in the human condition (Myslobodsky & Weiner, 2000).  There are currently two 
major lines of neurodevelopmental animal models. 
 Rather than attempting to reproduce specific putative causative factors implicated 
in schizophrenia, the first line of models simply attempt to mimic molecular, cellular, 
and/or systemic aberrations that presumably follow a disruption of early development 
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analogous to what has been described in human studies (Myslobodsky & Weiner, 2000).  
This can be accomplished, for example, via lesions or in utero exposure to mitotic toxins.  
The neonatal hippocampal lesion model, for instance, attempts to reproduce a putative 
defect in schizophrenia by lesioning of the ventral hippocampus in neonatal rodents 
(Lipska, Aultman, Verma, Weinberger, & Moghaddam, 2002; Tseng, Chambers, & 
Lipska, 2009).  The absence of proper hippocampal innervation at a critical 
neurodevelopmental period likely has long-term consequences on synaptic connectivity 
and function of neural circuits in the prefrontal cortex (Tseng et al., 2009).  Indeed, adult 
rodents exposed to such a neonatal manipulation have been shown to exhibit enhanced 
amphetamine-induced locomotion, deficits sensorimotor gating, social interaction, and 
working memory.  The MAM (methylazoxymethanol) model attempts to reproduce 
micrencephaly that has been noted following prenatal exposure to alcohol, irradiation, 
and cocaine, by administering MAM to pregnant rats at gestation days 14 or 15 (D.  J.  
Lodge & Grace, 2007).  A more than 50% decrease in cortical thickness in the offspring 
has been observed accompanied by motor hyperactivity and deficits in working memory 
(D.  J.  Lodge & Grace, 2007).  As models of developmental pathology, these models 
represent a rather crude technique, but provide important information about the function 
of restricted brain areas and neural connections between them.   
  The second line of models attempt to test the plausibility of various etiological 
hypotheses of schizophrenia including malnutrition, obstetric complications, viral 
infections, and early postnatal stress.  For instance, to investigate the influence of 
systemic viral and bacterial infection during pregnancy, pregnant rats and mice can be 
injected with viral mimetic polyriboinosinic-polyribocytidilic acid (poly I:C), and 
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lipopolysaccharide (LPS), respectively (Boksa, 2010; Meyer & Feldon, 2012).  Rather 
consistently, the offspring of pregnant rats injected with poly I:C or LPS have been 
shown to display augmented AMPH- and MK-801-induced locomotor activity, deficits in 
sensorimotor gating and working memory, and increased DA release in the nucleus 
accumbens (Boksa, 2004, 2010).  Expanding on this work, some researchers have begun 
to explore combinations of environmental and/or genetic factors in a “two-hit” hypothesis 
of schizophrenia.  This two-hit hypothesis posits that a first hit, such as genetic 
vulnerability or an environmental challenge (e.g. prenatal infection) produces a 
vulnerability, whereas a second hit at a later point in development induces the onset of 
the illness (Maynard, Sikich, Lieberman, & LaMantia, 2001).  For instance, researchers 
have shown evidence for a synergistic effect of prenatal poly I:C and pubertal 
cannabinoid exposure on the development of the serotoninergic system in the 
hippocampus (Dalton, Verdurand, Walker, Hodgson, & Zavitsanou, 2012) 
Aim of thesis 
 Given the apparent robustness of the poly I:C model of maternal infection, our 
aim in Chapter 1 was to replicate these findings and establish this model in our laboratory 
with the long-term goals of exploring 1) the common neuromechanisms underlying 
schizophrenia and substance abuse, and 2) exploring the effects of substance abuse in 
adolescent rats that have been prenatally exposed to infection, thus testing a two-hit 
hypothesis of schizophrenia.  Inspired by the NMDA receptor hypoactivity hypothesis of 
schizophrenia, our goal in Chapter 2 was to develop a novel animal model of 
schizophrenia-like behaviours involving prenatal exposure to the NMDA receptor 
antagonist, MK-801.  More specifically, the goal was to assess the effectiveness of this 
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model by examining whether it could model key deficits observed in other models of 
schizophrenia-like behaviours (e.g. drug-induce hyperactivity, memory deficits) as well 
as behaviours that are thought to model symptoms of schizophrenia that are resistant to 
current antipsychotic medications (e.g. deficits in cognitive flexibility, social interaction, 
etc.), and likely under the control of neurotransmitter systems other than dopamine.  
Moreover, in both chapters, we sought to examine whether these deficits are manifested 
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There is a substantial amount of epidemiological evidence supporting an 
association between maternal infection and schizophrenia (Fatemi & Folsom, 2009; 
Machon, Mednick, & Schulsinger, 1983; Watson, 1984).  The first indirect evidence for 
this association came from the observation of a higher prevalence of schizophrenia in 
individuals born to winter pregnancies, possibly due to higher prevalence of respiratory 
infections during this season (Watson, 1984).   A higher prevalence rate for schizophrenia 
has also been found in the offspring of women who were pregnant during influenza 
epidemics (Machon et al., 1983).   In support of this, researchers have indicated 
significant associations between schizophrenia in the offspring and maternal 
serologically-documented infections, including rubella, herpes simplex-virus-2, and 
maternal bacterial infections (A.  S.  Brown & Derkits, 2010).   Given the substantial 
amount of evidence for this association, a large body of research in developmental 
psychiatry has been aimed at examining the effects of maternal infection during 
pregnancy and its effects on the developing fetal brain.  Human studies have been useful 
in furthering our understanding of the effects of maternal infection on the development of 
the brain.  However, the empirical study of the effects of maternal infection on the 
development of the brain in humans is constrained by many ethical and practical 
difficulties.  Thus, researchers have turned to the use of animal models. 
 Researchers have used rodents to investigate the consequences of maternal 
exposure to a variety of immunogenic agents on offspring brain development and 
behaviour (Boksa, 2010; Meyer & Feldon, 2012).   One important behavioural paradigm 
commonly used in these studies is prepulse inhibition (PPI) of the acoustic startle 
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response.  The acoustic startle response is a full body skeletomuscular response to 
sudden, and loud acoustic stimuli which can be modulated by the presentation of a weak 
acoustic prepulse shortly before the startling stimulus (Wolff & Bilkey, 2010).  PPI 
reflects a preattentive sensorimotor gating mechanism which acts to preserve the 
processing of the prepulse from distracting stimuli such as the startle stimulus.  The 
ability to demonstrate a deficit in PPI is therefore considered to be a hallmark feature of 
animal models of schizophrenia.  Other behavioural paradigms commonly employed in 
maternal immune activation studies include sensitivity to the locomotor-activating effects 
of psychostimulant drugs (to assess for mesolimbic DA hyperactivity), and novel object 
preference (to assess for deficits in recognition memory) (Boksa, 2010).   
Initial approaches to examine the effects of maternal infection on offspring brain 
development and behaviour used prenatal infection with influenza virus followed by the 
application of a battery of behavioural tests, relevant to various deficits associated with 
schizophrenia, in the adult offspring (Shi, Fatemi, Sidwell, & Patterson, 2003).  Results 
from these studies showed that adult offspring born to infected dams presented decreased 
social interaction, reduced exploration in the open field (index of anxiety), impaired 
performance in the novel object preference task, and impaired PPI of the acoustic startle 
response (Shi et al., 2003).  Subsequent studies investigated the consequences of maternal 
infection using molecular immunogens.  The viral mimic, polyriboinosinic-
polyribocytidilic acid (poly I:C), has been used to stimulate the maternal immune system 
at several stages of pregnancy in mice or rats, ranging from GD 9 until GD 17 (Boksa, 
2010; Meyer & Feldon, 2010).   
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Prenatal challenge with poly I:C induces deficits in PPI of the acoustic startle 
response and in latent inhibition of conditioned learning (a task measuring associative 
learning and selective attention) (Meyer & Feldon, 2012).  In addition, these offspring 
show decreased social interaction, impaired novel object recognition, and impairments in 
spatial working memory (Meyer, Feldon, Schedlowski, & Yee, 2005; Meyer, Nyffeler, 
Yee, Knuesel, & Feldon, 2008; Shi et al., 2003; Vuillermot, Weber, Feldon, & Meyer, 
2010; Wolff & Bilkey, 2008; Zuckerman & Weiner, 2005).  These behavioural 
alterations are thought to model some of the negative and cognitive symptoms of 
schizophrenia.  Prenatal exposure to poly I:C has also been reported to evoke increased 
sensitivity to the locomotor activating effects of MK-801 and amphetamine (Meyer et al., 
2005; Ozawa et al., 2006; Smith, Li, Garbett, Mirnics, & Patterson, 2007; Vuillermot et 
al., 2010; Zuckerman & Weiner, 2005).  Importantly, some of the alterations in behaviour 
have been shown to appear in the adult but not in juvenile offspring (Ozawa et al., 2006; 
Romero, Guaza, Castellano, & Borrell, 2008; Vuillermot et al., 2010; Zuckerman & 
Weiner, 2003), as occurs in schizophrenia.  Also of significance is the observation that a 
number of behavioural alterations have been shown to be reversed by either acute or 
chronic treatment with several antipsychotic drugs (Meyer, Nyffeler, Yee, et al., 2008; 
Ozawa et al., 2006; Romero, Guaza, Castellano, & Borrell, 2010; Shi et al., 2003; 
Zuckerman & Weiner, 2005).   
Given the central role of DA in schizophrenia, several studies have investigated 
the effects of prenatal poly I:C on this neurotransmitter system.  One common approach 
is the measurement of tissue DA and its metabolites, 3,4-dihydroxyphenylacetic acid 
(DOPAC) and homovanillic acid (HVA).  These metabolites are the product of the 
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enzymatic degradation of DA by the monoamine oxidase (MAO) and catechol-O-methyl 
transferase (COMT).  HVA/DA or DOPAC/DA ratios are often used as a measure of the 
turnover of this neurotransmitter.  Prenatal poly I:C treatment (i.v., 4 mg/kg) at GD 15 
resulted in enhanced release of DA in the striatum in adult offspring (Zuckerman, Rehavi, 
Nachman, & Weiner, 2003).  Poly I:C treatment (i.v., 5 mg/kg) at GD 9 has been reported 
to increase DA and its major metabolites DOPAC and HVA levels in the PFC in the adult 
offspring (Winter et al., 2009).  Along the same lines, repeated injections of poly I:C (i.p., 
5 mg/kg, GD 12-17) increased levels of DOPAC and HVA in the adult striatum (Ozawa 
et al., 2006).   
Several other structural and neurochemical alterations that parallel the 
pathophysiological features of schizophrenia have been reported in the offspring of 
rodents born to poly I:C-treated dams.  For instance, prenatal poly I:C has been shown to 
result in enlarged lateral ventricles  which are commonly reported in post-mortem brains 
of patients with schizophrenia (L.  Li et al., 2009).  In addition, there have been reports of 
decreased hippocampal neurogenesis (Meyer, Schwendener, Feldon, & Yee, 2006) as 
well as decreased dendritic arborisation, especially in the CA1 (Baharnoori, Brake, & 
Srivastava, 2009).  There are also reports of alterations in GABA and glutamate 
neurotransmitter systems in the hippocampal formation (Meyer et al., 2006; Winter et al., 
2009).   
Collectively, the effects of prenatal poly I:C in the offspring are consistent with 
the epidemiological link between maternal infection and schizophrenia in humans.  
Moreover, these results suggest that immune activation during gestation via poly I:C 
treatment can induce changes in neurodevelopment that result in robust alteration of brain 
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function and behaviour in the adult offspring.  The poly I:C model of schizophrenia-like 
symptoms thus appears to be a reasonable place to begin exploring the combined 
consequences of prenatal and adolescent environmental challenge.  The first step in such 
an endeavour is, of course, to replicate previous findings with the poly I:C model.  
Therefore, the overarching goal of the work presented in this first chapter was to replicate 
the findings that prenatal exposure to poly I:C would result in altered behaviour and 
neurochemistry in the adult offspring.  We hypothesized that adult rats born to poly I:C-
treated dams would exhibit deficits in object recognition memory, enhanced sensitivity to 
the locomotor activating effects of amphetamine, and impaired PPI of the startle 
response.  Importantly, we predicted that these deficits would be manifested in adult, but 
not juvenile offspring.   
Materials & Methods 
Subjects  
 Timed pregnant Wistar dams (Gestation day (GD) 7; Charles River Laboratories, 
Québec, Canada) were individually housed in a colony room on a 12 h light-dark cycle 
(lights on at 8:00 AM; 21˚C) with ad libitum access to food and water.  Females were 
weighed daily in an effort to monitor their pregnancies and habituate them to daily 
handling.  At GD 15, dams were mildly restrained in a towel and given an intravenous 
injection of either 0.9% saline (n = 4) or 8.0 mg/kg poly I:C via the tail vein (n = 5).  
Dams were otherwise left undisturbed until the day after parturition.  The day of 
parturition was designated postnatal day (PND) 0.  On PND 1, litters were weighed and 
culled to 10 pups per litter (5 males and 5 females when possible).  Litters were left 
undisturbed until weaning at PND 21 and housed with same-sex offspring of the same 
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treatment condition.  Different sets of rats were tested during the juvenile period (PND 
30-40) and adulthood (PND 70+).  All behavioural testing was conducted during the light 
phase of the cycle.  All experiments were performed in accordance with the guidelines of 
the Canadian Council of Animal Care and all animal procedures were approved by the 
Animal Research Ethics Committee of Concordia University. 
Apparatus & Procedure 
 IL-6 plasma level assessment.  Researchers have reported batch and lot 
variations in the pyrogenic and cytokinogenic activity of commercial poly I:C (L.  
Harvey & Boksa, 2012).  Thus, the dosage for poly I:C was determined during a 
preliminary experiment as follows.  We obtained samples of poly I:C from two 
independent batches (all from Sigma – Aldrich, Canada).  Female non-pregnant rats 
received an intravenous injection via the tail vein of 4.0 mg/kg poly I:C from batch 1 (n = 
2), 4.0 mg/kg poly I:C from batch 2 (n = 2), 8.0 mg/kg poly I:C from batch 1 (n = 2), 8.0 
mg/kg poly I:C from batch 2 (n = 2), or 0.9% saline (n = 4) and IL-6 responses were 
compared.  IL-6 is the primary circulating pro-inflammatory cytokine mediating the acute 
phase inflammatory response (Heinrichs, 2005) and previous studies have shown that, in 
rats, an intravenous injection of poly I:C at GD 15 results in peak elevations of IL-6 in 
the dams’ blood, 6 h after injection.  Thus, blood was collected in ice-cold vials 6 h after 
injection and immediately centrifuged.  Plasma was stored at - 80˚C until being assayed 
for IL-6 using a commercially available ELISA kit (R&D Systems, Minneapolis, MN).  
The range of the assay is between 0 and 4000 pg/mL and the reported inter-assay 
variation is 7-10%.   
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 Maternal behaviour and pup weights.  Maternal behaviour of SAL (n = 4) and 
poly I:C treated dams (n = 5) was observed twice a day each day for the first 14 days 
following parturition to assess whether the prenatal manipulation resulted in differences 
in dam behaviour.  A rater made observations once per minute in 10-min increments at 
two different times (09:30 and 16:00 hrs).  As previously described (Priebe et al., 2005) 
maternal behaviours observed included: (1) arched-back nursing; dam is in an arched 
position over the nursing pups, (2) nursing prone; dam is lying on its side while pups are 
nursing, (3) grooming/licking, (4) nest building, and (5) off-nest.  Maternal behaviours 
were converted to a percentage of the number of times the dam engaged in each of these 
behaviors over the total number of time points observed (e.g. 1 observation/min/dam X 
10 min/session X 2 sessions/day X 14 days = 280 observations/dam).  Pups (Males: SAL, 
n = 24; poly I:C, n = 15; Females: SAL, n = 22; poly I:C, n = 21) were weighed at PND 
1, 8, 14, and 21.   
 Novel object preference (NOP).  An open field arena (60 cm x 70 cm x 70 cm) 
constructed of gray PVC plastic with a stainless steel flooring covered with wood chip 
bedding was used.  A web camera was positioned above the arena and both the 
familiarization and test phases were recorded for later analysis.  Objects made of glass, 
porcelain, or glazed ceramic and varying in height between approximately 6 and 12 cm 
were used as test stimuli.  The objects were attached with epoxy to a small glass jar (6 cm 
high) and two inverted jar lids were attached to the arena floor each at 27 cm from 
opposing corners of the arena.  Objects were fixed in place by screwing the jars into the 
lids (Figure 2).  There were three copies of each object.  All objects used have been tested 








Figure 2.  (A) Familiarization phase and (B) retention phase of the novel object 






a similar amount of investigation.   Objects used as the novel stimulus and their position 
in the box were counterbalanced.  Rats were tested during the juvenile period (Males: 
SAL, n = 8; poly I:C, n = 6; Females: SAL, n = 6; poly I:C, n = 9) or in adulthood 
(Males: SAL, n = 7; poly I:C, n = 8; Females: SAL, n = 6; poly I:C, n = 9).  The task was 
divided into three phases: habituation, familiarization, and retention test (Gaskin et al., 
2010).   
 Habituation.  Rats were individually placed inside the arena with two identical 
objects for 10 min on two consecutive days.  NOP testing began 24 hrs after the second 
habituation session.    
 Familiarization.  Rats were placed into the arena containing two copies of the 
sample object, for 5 min.  During the familiarization phase, total exploration time was 
recorded to ensure that there were no statistically significant differences between 
treatment conditions and that rats explored for a minimum of 1 min.  Rats were returned 
to their home cages for a delay period.  The delays used were 90 sec, 15 min, and 4 hrs.   
 Retention test.  Following the delay, rats were placed inside the arena for 5 min 
with a copy of the sample object and a novel object.  Object investigation was defined as 
the rat's head facing, touching, and/or sniffing the object at a distance of or less than 2 
cm.  Climbing or sitting on objects was not considered investigation.  Investigation times 
were recorded using ODLog version 2.7.2 (Macropad, software) and an investigation 
ratio was computed for the retention test.  This investigation ratio consisted of the time 
spent investigating the novel object relative to total object investigation (tnovel/(tnovel + 
tfamiliar)) during the first minute of the test because investigation of the novel object 
subsides as the trial progresses (Dix & Aggleton, 1999).   
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 Drug-induced locomotor activity.  Locomotor activity was quantified with an 
infrared activity-monitoring apparatus for rats (Truscan, Coulbourn Instruments, 
Whitehall, PA, USA).  The apparatus were clear polyethylene test chambers 39 cm X 42 
cm X 50 cm with 16 light-emitting diode photodetector pairs located along the base and 
spaced every 2.5 cm.  Data were captured using Trusacan2 software in total distance 
traveled (successive beam interruptions (cm)).  All rats were tested throughout the 
experiment in the same respective activity chamber at the same time of day. 
 Juvenile.  SAL (Males: n = 5; Females: n = 6) and poly I:C (Males: n = 5; 
Females: n = 8) rats were  tested during the juvenile period.  On day 1, rats were placed 
in the box for 30 min prior to injection.  Following this habituation period, all rats 
received an injection of 0.9% saline (i.p.) and were left in the activity chamber for an 
additional 90 min.  On days 2 and 3, rats underwent the same procedure but received an 
i.p.  injection of 0.75 mg/kg and 1.0 mg/kg amphetamine respectively. 
 Adults.   Drug-naive SAL (Males: n = 6; Females: n = 6) and poly I:C (Males: n = 
7; Females: n = 8) rats were  tested during adulthood.  Rats were tested under the same 
protocol and same doses described above for the juvenile period.   
 Prepulse inhibition of the acoustic startle response.   At PND 22, male (SAL: n 
= 5; poly I:C: n = 8) and female (SAL: n = 6; poly I:C: n = 8) drug-naive offspring were 
transported to the Douglas Mental Health University Institute where they were left 
undisturbed for an acclimatization period of 10 days prior to testing.   All testing occurred 
over one day.  PPI was measured in 4 startle chambers (San Diego Instruments, San 
Diego, CA) consisting each of a Plexiglas tubes mounted on a Plexiglas base within a 
sound-attenuating chamber.  Chamber assignment was counterbalanced for prenatal 
 30 
 
treatment and chambers were cleaned with a 70% alcohol solution between animals.   A 
piezoelectric strain meter attached to the base transduced the startle response and was 
digitized and recorded by a computer.  A speaker located in the ceiling of the sound 
attenuating chamber presented all acoustic stimuli and maintained a constant background 
noise level of 70 dB.  Startle reactivity was assessed by exposing animals to a 40 ms, 120 
dB acoustic stimulus alone.  An average of fifty 1-ms readings, beginning at the onset of 
the startle stimulus, was used as the dependent variable.  PPI of acoustic startle responses 
was measured by having the 120 dB startle stimulus proceeded by a 20 ms prepulse 
stimulus of 4, 8, 12, and 16 dB above background, which terminated 80 ms before the 
onset of the startle stimulus (prepulse-pulse trials).  The testing session consisted of 12 
startle-only trials, 12 no-stimulus (null) trials, and 24 prepulse-pulse trials.  Each session 
began with a 5 min acclimation period of background noise.  This was followed by trials 
arranged in pseudorandom order to prevent consecutive presentations of the same trial 
type.  The degree of PPI of acoustic startle response was calculated as a percentage for 
each prepulse intensity using the following formula:  
100% X (1- (mean prepulse trial – mean null)/(mean startle – mean null)) 
 Drugs.  D-Amphetamine sulfate (AMPH, Sigma-Aldrich) was dissolved in 0.9% 
saline.  Poly I:C (Sigma-Aldrich) was dissolved in 0.2 mL phosphate buffered saline 
(PBS).   
Statistical Analysis 
 All statistical analyses were conducted using SPSS version 22 for Windows 
(IBM, Chicago, IL).  All variables of interest were assessed for normality and equality of 
variance.  In all t-tests where the Levene’s test for equality of variance was violated, 
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corrected degrees of freedom were used.  Likewise, in all Analyes of variance 
(ANOVAs) where the Mauchly’s test of sphericity was violated, the Greenhouse-Geisser 
correction was used.  Effect sizes were computed for all tests.  For t-tests, Cohen’s d were 
calculated when sample sizes were equal while Hedge’s g was calculated for unequal 
samples sizes (Cohen, 1988; Hedges & Olkin, 1985).  Partial eta squared was calculated 
for all ANOVAs.   
 Maternal behaviour and pup weights.  Independent samples t-tests were used to 
compare SAL and poly I:C-treated dams on each of the maternal behaviours.  Treatment 
condition (SAL vs.  Poly I:C) served as the independent variable while percentage 
frequency of behaviour served as the dependent variable  Independent samples t-tests 
were also used to compare body weights of SAL and poly I:C pups at each of the four 
PNDs with treatment condition serving as the independent variable and body weight 
serving as the dependent variable.   
Novel object preference.  A one sample t-test was used to compare each group's 
investigation ratio to chance (0.5).  Prenatal treatment (SAL vs.  Poly I:C) served as the 
independent variable while investigation ratio served as the dependent variable.  
Investigation ratios that were significantly above chance level indicated that rats 
displayed preference for the novel object, suggesting that rats recognized the familiar 
object.   
 Drug-induced locomotor activity.  Although it is customary to display and 
analyze locomotor activity data across time, we were unable to retrieve the activity data 
across time due to technical difficulties.  As a result, activity data in this chapter are 
presented as total distance traveled during the entire session.  Independent samples t-tests 
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were used to compare SAL and poly I:C rats on each testing day.  Prenatal treatment 
served as the independent variable while total distance travelled (cm) served as the 
dependent variable.  
 Prepulse inhibition of the acoustic startle response.  Independent samples t-
tests were used to compare SAL and poly I:C rats in null trials and startle-only trials.  
Prenatal treatment was used as the independent variable while movement was used as the 
dependent variable.  A 2 X 4 mixed ANOVA was used to analyze PPI.  Prenatal 
treatment (SAL, poly I:C) served as the between-subject factor while prepulse intensity 
(4, 8, 12, 16) served as the within-subject factor.   
Results 
Maternal behaviour and pup weights 
 There were no statistically significant differences between poly I:C- and saline-
treated dams on any of the five assessed maternal behaviours (Figure 3).  Thus, the 
treatment condition did not affect the way in which dams cared for their offspring during 
the first 14 days of life.  Body weights of both male and female poly I:C and SAL 
offspring did not differ significantly at PND 1, 8, 14, and 21 (Figure 4).   
Novel object preference 
 Males 
 Juvenile.  Following a 90 sec delay, the poly I:C rats showed statistically 
significant preference for the novel object, t(7) = 3.18, p = .015, d = 1.12, while the SAL 
rats did not, t(5) = 1.17, p = .296, d = 0.48.  Following a 15 min delay however, neither 
the SAL, t(6) = 1.23, p = .266, d = 0.46, or poly I:C rats, t(6) = 0.90, p = .403, d = 0.34, 






Figure 3.  Mean (± SEM) percentage of number of times Saline and poly I:C dams 
engaged in maternal behaviours.  At gestation day 15, dams were given an intravenous 
injection of either 0.9% saline or 8.0 mg/kg poly I:C via the tail vein.  See text for 


























































Figure 4.  Mean (± SEM) body weights of (A) male and (B) female offspring at postnatal 

















































was observed following a 4 h delay in neither the SAL, t(6) = 0.96, p = .374, d = 0.36, or 
poly I:C rats, t(8) = 1.40, p = .205, d = 0.49 (Figure 5 A).   
 Adults.  As seen in Figure 5 B, following a 90 sec delay both the SAL, t(6) = 
3.50, p = .013, d = 1.32, and poly I:C rats, t(7) = 7.74, p = .000, d = 2.74, showed 
statistically significant novel object preference.  After a 15 min delay, both the SAL, t(6) 
= 4.01, p = .007, d = 1.52, and poly I:C rats, t(7) = 5.49, p = .001, d = 1.94, continued to 
show significant preference for the novel object.  However, following a 4 h delay, neither 
the SAL, t(6) = 1.25, p = .257, d = 0.47, nor the poly I:C rats, t(7) = 1.82, p = .276, d = 
0.42, showed statistically significant novelty preference.   
 Females 
 Juvenile.  As seen in Figure 6 A, following a 15 min delay, neither the SAL, t(5) 
= 0.59, p = .581, d = 0.24, nor the poly I:C, t(8) = 2.03, p = .077, d = 0.68, rats showed 
statistically significant novelty preference.  The same was observed following a 4 h delay 
where neither the SAL, t(5) = 0.74, p = .494, d = 0.19, nor the poly I:C, t(8) = 1.44, p = 
.187, d = 0.45, rats showed preference for the novel object.   
 Adults.  As seen in figure 6 B, following a 90 sec delay, both the SAL, t(5) = 
10.16, p = .000, d = 10.16, and poly I:C rats, t(8) = 9.24, p = .000, d = 9.24, showed 
statistically significant novelty preference.  After a 15 min delay, both the SAL, t(5) = 
3.83, p = .012, d = 3.83, and poly I:C rats, t(8) = 4.77, p = .001, d = 4.77, continued to 
show significant preference for the novel object.  However, following a 4 h delay, the 
SAL rats, t(5) = 6.17, p = .002, d = 6.17, showed preference for the novel object while the 









Figure 5.  Mean (±SEM) investigation ratio for the first min of the novel object 
preference test sessions for (A) juvenile prenatal Saline and poly I:C and (B) adult 



























































Figure 6.  Mean (±SEM) investigation ratio for the first min of the novel object 
preference test sessions for (A) juvenile Saline and poly I:C and (B) adult Saline poly I:C 
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Amphetamine-induced locomotor activity 
 Males 
 Juvenile.  As seen in Figure 7 A, following the saline injection, there were no 
statistically significant differences between SAL and poly I:C rats in total distance 
travelled, t(8) = 0.19, p = .854, g = 0.12.  The total distance travelled observed following 
a low dose of amphetamine (0.75 mg/kg),appeared to be higher in the poly I:C rats 
compared to the SAL rats, but the difference was not statistically significant, t(5.21) = 
1.79, p = .132, g = 1.13.  However, following a high dose of amphetamine (1.0 mg/kg), 
poly I:C rats' total distance travelled was again higher than in the SAL rats, and this 
group difference approached statistical significance, t(8) = 2.11, p = .068, g = 1.33.   
 Adulthood.  Following the saline injection, there were no statistically significant 
differences in total distance travelled between SAL and poly I:C rats, t(11) = 0.82, p = 
.432, g = 0.45.  Similarly, no differences in total distance travelled were observed 
between SAL and poly I:C rats following a low dose of amphetamine (0.75 mg/kg),  t(11) 
= 0.187, p = .855, g = 0.10, or a high dose of amphetamine (1.0 mg/kg), t(11) = 0.36, p = 
.726, g = 0.20 (Figure 7 B).   
 Females 
 Juvenile.  As seen in figure 8 A, there were no differences in total distance 
travelled between SAL and poly I:C rats following an injection of saline, t(12) = 0.86, p = 
.407, g = 0.49.  Similarly, no differences in total distance travelled were observed 
between SAL and poly I:C rats following a low dose of amphetamine (0.75 mg/kg),  t(12) 
= 1.67, p = .122, g = 0.94, or a high dose of amphetamine (1.0 mg/kg), t(12) = 0.28, p = 







Figure 7.  Mean (±SEM) total distance travelled for (A) juvenile Saline and poly I:C and 
(B) adult Saline and poly I:C male offspring.  Locomotor activity was assessed following 






































































Figure 8.  Mean (±SEM) total distance travelled for (A) juvenile Saline and poly I:C and 
(B) adult Saline and poly I:C female offspring following an amphetamine injection (0.0, 
0.75, 1.0 mg/kg; i.p.).  *Significantly different, p < 0.05.  Locomotor activity was 
assessed following acute injections of saline or amphetamine (0.75, 1.0 mg/kg; i.p.) 










































































 Adulthood.  As was observed in juvenile females, there were no differences in 
total distance travelled between SAL and poly I:C adult females following an injection of 
saline, t(12) = 0.55, p = .592, g = 0.30 (Figure 8 B).  Interestingly, following a low dose 
of amphetamine (0.75 mg/kg), poly I:C rats moved significantly less than SAL rats, t(12) 
= 2.67, p = .021, g = 1.44.  However, following a high dose of amphetamine (1.0 mg/kg), 
there were no statistically significant differences between SAL and poly I:C rats in 
distance travelled, t(12) = 0.29, p = .777, g = 0.16.   
Prepulse inhibition of acoustic startle response 
 Males 
 Baseline measures.  As seen in Figure 9 A, there were no statistically significant 
differences between SAL and poly I:C rats in the magnitude of activity during the null 
trials, t(11) = 0.20, p = .848, g = 0.11.  Similarly, no statistically significant differences 
were found between SAL and poly I:C rats in the magnitude of response during the 
startle-only trials, t(11) = 0.63, p = .544, g = 0.36.  The results from these baseline 
measures indicate that the prenatal treatment did not influence baseline activity within the 
chamber or general reactivity or sensitivity to the startle pulse.  Thus, potential 
differences observed in prepulse inhibition cannot be attributed to baseline differences.   
 PPI.  As illustrated in figure 9 B, the ANOVA revealed a statistically significant 
main effect for prepulse intensity, F (3, 33) = 10.66, p < .001, p
2 
= 0.49.  Simple 
contrasts indicated that percent PPI increased significantly as the prepulse intensity 
increased, F (1, 12) = 22.29, p < .001, p
2 
= 0.65, suggesting that louder prepulses were 
more effective at inhibiting the startle response to the pulse.  However, there were no 







Figure 9.  Mean (±SEM) of (A) magnitude of response in null trials and startle-only trials 
and (B) percent prepulse inhibition of the acoustic startle response in Saline and poly I:C 
































































treatment: F (1, 11) = 1.96, p = .189, p
2 
= 0.15.  The prenatal treatment by prepulse 
intensity interaction was not statistically significant, F (3, 33) = 1.52, p = .227, p
2 
= 0.12.   
Females 
 Baseline measures.  As was found with male offspring, there were no statistically 
significant differences between SAL and poly I:C female rats in the magnitude of activity 
during the null trials, t(12) = 0.40, p = .693, g = 0.22, or in the magnitude of response 
during the startle-only trials, t(12) = 0.43, p = .672, g = 0.23 (Figure 10 A).   
 PPI.  As was the case for male rats, the ANOVA revealed a statistically 
significant main effect for prepulse intensity, F (3, 26) = 7.40, p < .001, p
2 
= 0.46, with 
simple contrasts again indicating that percent PPI increased significantly as the prepulse 
intensity increased, F (1, 12) = 22.29, p < .001, p
2 
= 0.65 (Figure 10 B).  There were no 
differences between SAL and poly I:C rats in PPI at any of the intensities, prenatal 
treatment: F (1, 12) = 0.03, p = .870, p
2 
= 0.002, and the prenatal treatment by prepulse 
intensity interaction was not statistically significant, F (3, 36) = 0.39, p = .760, p
2 
= 0.03.   
Summary 
 No differences were found in maternal behaviour between SAL and poly I:C-
treated dams suggesting that treatment condition did not impact the way in which dams 
cared for their offspring during the first 14 days following parturition.  It was thus 
deemed safe to assume that any observed behavioural differences between SAL and poly 
I:C offspring were not the result of differences in maternal care.  Our hypothesis that poly 
I:C offspring would have lower weights compared to SAL offspring was not supported, 








Figure 10.  Mean (±SEM) of (A) magnitude of response in null trials and startle-only 
trials and (B) percent prepulse inhibition of the acoustic startle response in Saline and 































































 Hypotheses regarding NOP in male rats were not supported.  During the juvenile 
period, male poly I:C rats showed NOP following a 90 sec delay while the SAL rats did 
not.  Both the SAL and poly I:C male rats failed to show NOP following 15 min and 4 h 
delays.  However, in adulthood, both the SAL and poly I:C male rats showed NOP at the 
90 sec and 15 min delays, suggesting that the rats recognized the familiar object after 
these delays.  Following the 4 h delay however, neither the SAL nor poly I: C males 
showed NOP possibly suggesting that they could no longer recognize the familiar object 
after such a long delay.  Contrary to our hypothesis, NOP deficits were not limited to rats 
born to poly I:C-treated dams.  The same pattern of results was observed in juvenile 
female rats where no object preference was observed in either of the groups following all 
delays.  As was the case with adult males, both SAL and poly I:C adult females showed 
NOP following 90s and 15 min delays.  Interestingly, our hypothesis was supported 
following a 4 h delay where the SAL females showed NOP while the poly I:C females 
did not, suggesting that prenatal exposure to poly I:C disrupted object recognition in 
females at a longer delay.   
 Our overall hypotheses concerning AMPH-induced locomotor activity were not 
supported.  As expected, there were no differences between SAL and poly I:C juvenile 
male rats following saline injections.  Following both the 0.75 mg/kg and 1.0 mg/kg 
AMPH challenges, there were no differences between the two treatment groups, though 
there appeared to be a trend for higher locomotor activity in the poly I:C rats compared to 
SAL rats.  This trend disappeared, however, in adult male rats where no differences 
between SAL and poly I:C rats were observed following any of the challenges.  In 
juvenile female rats, as hypothesized, there were no differences between treatment groups 
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following any of the injections.  Interestingly and contrary to our hypothesis, the poly I:C 
adult female rats exhibited lower locomotor activity compared to the SAL adult females 
following the 0.75 mg/kg AMPH challenge, suggesting that prenatal exposure to poly I:C 
decreased sensitivity to the locomotor activating effects of AMPH.  However, this result 
was not observed following the 1.0 mg/kg AMPH challenge.   
 Our hypotheses regarding PPI of the acoustic startle response in juvenile rats were 
supported.  In both juvenile male and female rats, louder prepulses resulted in higher 
percent PPI, suggesting that louder prepulses were more effective at inhibiting the startle 
response to the pulse.  As expected, there were no differences between SAL and poly I:C 
rats in percent PPI of the acoustic startle response suggesting that sensorimotor gating 
was not impaired.  Unfortunately, these results are inconclusive as we were unable to 


















BEHAVIOURAL AND NEUROCHEMICAL CONSEQUENCES OF CHRONIC 





















As previously discussed, the use of the NMDA receptor antagonist, PCP, as an 
anesthetic in the 1950s revealed that NMDA receptor blockade resulted in hyperactivity, 
hallucinations, and cognitive impairment in healthy individuals (Bakker & Amini, 1961; 
Davies & Beech, 1960; Luby et al., 1959).  Subsequent research illustrated that PCP 
exacerbated these existing symptoms in patients with schizophrenia (Neill et al., 2010).  
What followed was the birth of the glutamate hypothesis of schizophrenia which posits 
that symptoms of schizophrenia are, in part, the result of a hypoglutamatergic state that is 
mediated by NMDA receptor hypofunction (Duncan et al., 1999).   
This hypothesis does not exclude the DA hypothesis but rather proposes a way in 
which both neurotransmitter systems may interact to produce the symptoms observed in 
schizophrenia.  In fact, the observation that both typical and atypical antipsychotic drugs, 
which act primarily as DA antagonists, are effective in alleviating symptoms induced by 
NMDA receptor antagonism (e.g. social withdrawal, anhedonia, avolition) suggests an 
interaction between the two systems (Duncan et al., 1999).  In addition, NMDA receptor 
blockade has been shown to result in increased striatal DA release which, in animals, 
results in increased locomotor activity (Tang et al., 2006) and cognitive impairment 
(Jentsch, Tran, Taylor, & Roth, 1998).  Thus, the current hypothesis is that glutamatergic 
hypoactivity, via NMDA receptor hypofunction, may have downstream effects on the 
dopaminergic system resulting in a hyperactive mesolimbic DA system (Adams & 
Moghaddam, 1998).  To better comprehend the putative role of the NMDA receptor in 
schizophrenia, one must have a clear understanding of this interesting receptor’s structure 
and functioning.   
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 The NMDA receptor (Figure 11) contains two subunits: NR1, which is required 
for channel function, and NR2A-D, which is involved in the pharmacologic 
characteristics of the NMDA receptor (Monaghan & Jane, 2009).  In addition to the 
glutamate recognition site, a second site on the NR1 binds glycine and/or D-serine and 
must be occupied for glutamate to open the channel (Monaghan & Jane, 2009; Neill et 
al., 2014).  At resting membrane potential, the NMDA receptor is blocked my Mg
2+, 
which can be removed once the cell is depolarized.  Within the channel is a binding site 
for dissociative anaesthetics such as PCP, ketamine, and MK-801, which act as non-
competitive antagonists (Monaghan & Jane, 2009; Neill et al., 2014).   
 In order to experimentally examine the role of NMDA receptors in the 
pathophysiology of schizophrenia, researchers have assessed schizophrenia-like 
behaviours in response to treatment with receptor antagonists in rodents.  The general 
procedure involves injecting the adult rat or mice with an NMDA receptor antagonist and 
assessing, often immediately after the drug treatment, behaviours that are thought to 
model negative, cognitive, and to a limited extent, positive symptoms of schizophrenia.    
Research shows that prolonged exposure to PCP in adult mice results in increased 
immobility in the forced-swim test (Noda, Yamada, Furukawa, & Nabeshima, 1995).  
Although there is some controversy about whether increased immobility demonstrates 
adaptive learning rather than a depression-like symptom (Borsini, Volterra, & Meli, 
1986), the forced-swim test is a common procedure used in research with rodents to 
assess depression-like behaviour (i.e.  negative symptoms) (Xu et al., 2005).  In this task, 





















cylinder walls as a survival instinct.  Decreased latencies to immobility or increased 
immobility are thought to indicate depression-like behaviours (Borsini et al., 1986).   
As previously discussed, perseveration, the difficulty in inhibiting behaviours on a 
learned task, is a cognitive symptom associated with cognitive flexibility and frequently 
reported in patients with schizophrenia.  Researchers have shown that acute injections of 
MK-801 result in perseverative behaviour in rats trained in an operant chamber (Holahan, 
Clarke, & Hines, 2010).  In addition, researchers have found that NMDA receptor 
antagonism via MK-801 in rats aged PND 7 through 10 induced set-shifting deficits in 
rodents assessed in a maze-based set-shifting task (Stefani & Moghaddam, 2005).  In 
addition to perseveration, working memory is also reported to be impaired in 
schizophrenia and can be disrupted in rodents exposed to an NMDA receptor antagonist 
(Stefani & Moghaddam, 2005).  PCP-treated rats have been shown to display impaired 
performance in a working memory task using a T-maze (Adams & Moghaddam, 1998 
(Stefani & Moghaddam, 2005).  Finally, both PCP and MK-801 have been shown to 
disrupt object recognition and spatial memory in mice and rats (Neill et al., 2010).    
Although these models of schizophrenia-like behaviours using acute challenges 
with NMDA receptor antagonists have been useful in elucidating the role of glutamate, 
they fail to capture the neurodevelopmental nature of schizophrenia.  Given the evidence 
pointing to early developmental aberrations resulting in symptoms observed in adulthood, 
it is tempting to assume that prenatal manipulation of the glutamate system would result 
in structural and functional changes in the adult offspring brain.  Indeed, researchers have 
begun to expand the acute NMDA receptor antagonist models of schizophrenia-like 
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behaviours to include prenatal challenges to this system in an attempt to evaluate how 
this system may be linked to the neurodevelopmental etiology of schizophrenia.   
The results, thus far, suggest that prenatal disruption of the glutamatergic system 
via NMDA receptor blockade may indeed be linked to schizophrenia-like behaviours in 
adult offspring.  For instance, rats born to MK-801-treated dams (GD 15 – 18) show 
reduced post-pubertal density of parvalbummin-immunoreactive GABA neurons in the 
medial prefrontal cortex (Abekawa, Ito, Nakagawa, & Koyama, 2007).  In addition, these 
adult offspring showed increased sensitivity to the locomotor activating effects of PCP 
(Abekawa et al., 2007).  Another study found that prenatal PCP treatment (5 mg/kg/day; 
GD 6 – 18) in mice resulted in impaired object recognition memory and increased 
immobility in the forced-swim task in adult offspring (Lu et al., 2011).  These 
behavioural changes were accompanied by decreased extracellular glutamate in the PFC, 
and increased expression of a glial glutamate transporter (GLAST) in the PFC.  
Furthermore, when a GLAST antagonist was administered, prefrontal glutamatergic 
neurotransmission was enhanced resulting in reversal of the observed behavioural deficits 
were reversed (Lu et al., 2011).  In an earlier study, Lu et al.  (2010) showed that prenatal 
exposure to PCP in mice resulted in increased expression but reduced phosphorylation of 
NR1.  These results suggest that prenatal exposure to PCP result in schizophrenia-like 
symptoms and abnormal expression and dysfunction of NMDA receptors in adult mice 
(Lu et al., 2010).  In addition to these studies, unpublished findings from our 
collaborators suggest that chronic prenatal exposure to MK-801 (0.1 mg/kg/day; GD 7 – 
19) result in absence of novel object preference and altered locomotor response to an 
acute injection of MK-801 and amphetamine in the adult male offspring.  Furthermore, 
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pilot studies from our laboratory suggest that prenatal exposure to MK-801 results in 
suppressed latent inhibition and shorter latencies to immobility in the forced swim test in 
the adult offspring.   
Although the evidence thus far appears to suggest that prenatal alterations in the 
development of the glutamatergic system may be relevant to the etiology of 
schizophrenia, the adverse effects of prenatal exposure to NMDA receptor antagonists on 
a wide range of behaviours are not well understood.  Furthermore, the effects of such a 
prenatal manipulation on behaviour have been assessed in adult, but not juvenile rats.  
Therefore, the aim of Chapter 2 was to 1) replicate the effects of prenatal MK-801 
administration on locomotor activity and object recognition memory in adult rats; 2) 
expand on these findings by exposing the adult offspring to a large battery of behavioural 
tasks designed to model positive, negative, and cognitive-like symptoms; and 3) assess 
the effects of prenatal MK-801 exposure on behaviour in juvenile offspring.  We 
hypothesized that rats born to MK-801-treated dams would show schizophrenia-like 
symptoms compared to control rats, in adulthood, but not in the juvenile period.   
Materials & Methods 
Subjects 
 Female Long-Evans rats (n = 15, 225-250 g) were purchased from Charles River 
(St.  Constant, Quebec, Canada).  Rats were housed three per cage under a 12 h light-dark 
cycle (lights on at 8:00 AM; 21˚C) with ad libitum access to food and water and were 
allotted 1 week of acclimation prior to breeding.   One male breeder Long-Evans rat (n = 
5, 350-400 g) was added to each cage.  Vaginal smears were taken daily to monitor the 
female's estrous cycle and identify the period at which they were receptive.  Females 
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were weighed daily and examined for vaginal plugs (indicating mating).  The presence of 
a vaginal plug was defined as gestation day (GD) 0.  At GD 6, females were housed 
individually in clear standard shoebox cages for the remainder of gestation.  From GD 7 
to 19, dams received daily subcutaneous (s.c.) injections of either 0.9% saline (n = 6) or 
0.1 mg/kg MK-801 (n = 9).  One day following parturition, litters were culled down to 12 
pups per cage (6 males and 6 females when possible) to control for litter size effects.  At 
PND 21, pups were weaned and housed three per cage with their respective treatment 
group.  Different sets of rats were tested during the juvenile period (PND 30-40) and 
adulthood (PND 70+).  All behavioural testing was conducted during the light phase of 
the cycle.  All experiments were performed in accordance with the guidelines of the 
Canadian Council of Animal Care and all animal procedures were approved by the 
Animal Research Ethics Committee of Concordia University. 
Apparatus & Procedure 
 Maternal behaviour and pup weights.  Maternal behaviour of saline (SAL; n = 
5) and MK-801 (MK) treated dams (n = 5) was observed twice a day each day for the 
first 14 days following parturition to assess whether the prenatal manipulation resulted in 
differences in dam behaviour.  As described in Chapter 1, a rater made observations once 
per minute in 10-min increments at two different times (09:30 and 16:00 hrs).  Maternal 
behaviours observed included arched-back nursing, nursing prone, grooming/licking, nest 
building, and off-nest.  Maternal behaviours were converted to a percentage of the 
number of times the dam engaged in each of these behaviors over the total number of 
time points observed.  Pups were weighed at PND 2, 7, 14, and 21.    
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 Novel object preference.  The same apparatus and procedure described in 
Chapter 1 to assess NOP was used in the present experiment.  The task was divided into 
the three phases of habituation, familiarization, and retention test.  The delays used 
between the familiarization phase and retention test with juvenile rats (Males: SAL, n = 
9; MK, n = 11; Females: SAL, n = 6; MK, n = 8) were 90 sec, 15 min, and 4 hrs.  Delays 
used with adult rats (SAL, n = 9; MK, n = 11; Females: SAL, n = 8; MK, n = 11) were 15 
min, 90 min, and 4 hrs.  Investigation times were recorded using ODLog version 2.7.2 
(Macropad, software) and an investigation ratio (tnovel/(tnovel + tfamiliar)) was computed for 
the retention test.   
 Drug-induced locomotor activity.  Locomotor activity was quantified with the 
same infrared activity-monitoring apparatus described in Chapter 1.  Data were captured 
using Trusacan2 software in 5-min time intervals for total distance traveled (successive 
beam interruptions (cm)).  All rats were tested throughout the experiment in the same 
respective activity chamber at the same time of day.   
 Juvenile.  SAL (Males: n = 7; Females: n = 7) and MK (Males: n = 9; Females: n 
= 8) rats were tested during the juvenile period.  On day 1, rats were placed in the box for 
30 min prior to injection.  Following this habituation period, all rats received an injection 
of 0.9% saline (i.p.) and were left in the activity chamber for an additional 90 min.  On 
days 2 and 3, rats underwent the same procedure but received an i.p.  injection of 0.1 
mg/kg and 0.2 mg/kg MK-801 respectively.  After a 4 day washout period, rats were 
again tested under the same procedure but received an injection of saline (day 1), 0.75 
mg/kg amphetamine (day 2), and 1.0 mg/kg amphetamine (day 3). 
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 Adults.   Drug-naive SAL (Males: n = 8; Females: n = 8) and MK (Males: n = 8; 
Females: n = 8) rats were  tested during adulthood.  Rats were tested under the same 
protocol used in the juvenile period with a few dose adjustments.  All rats first received 
i.p.  injections of saline on day 1 and 0.1 mg/kg MK-801 on day 2.  On day 3, the females 
received an i.p.  injection of 0.2 mg/kg MK-801 while the males received 0.4 mg/kg MK-
801.   Following a one week washout period, all rats were tested under the same protocol 
but this time received saline (day 1), 0.75 mg/kg amphetamine (day 2), and 1.0 mg/kg 
amphetamine (day 3).  Males underwent an additional day of testing with a 1.5 mg/kg 
amphetamine challenge (day 4).   
 Delayed non-match to place task.  Working memory was assessed using an 
opaque T-maze placed on a table one meter above the ground.  The T-maze walls 
extended 28 cm above a wire grid flooring which measured 10.5 cm in width.  The roof 
of the maze was transparent.  Three arms were arranged at 90° angles around a 14 x14 cm 
central chamber and measured 75 cm in length.  Black polyurethane guillotine doors were 
used to open or close the entrance to the maze and to the goal arms from the central 
chamber.  Using a string attached on the ceiling above the maze, these gates could be 
lifted from a remote location thereby ensuring that the experimenter remained in the same 
location throughout the experiment.  The experimenter always stood directly behind the 
start box during training and testing.  A metal bowl was placed at the end of each goal 
arm and a food reward (1/4 of a Kellogg’s ®Froot Loops) was placed inside when 
appropriate.  Additionally, Froot Loop crumbs were placed directly underneath the maze 
in an effort to avoid confounds associated with olfactory cues.  The training and testing 
procedures took place in a dim-lighted room.   
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Adult male rats (nSAL = 7, nMK = 8) were placed on a food restriction diet in order to 
increase the salience of the reward.  Once rats reached 90% of their initial body weight, 
DNMTP began and consisted of three phases: habituation, acquisition, and testing.   
Habituation.  For three consecutive days, rats were allowed 15 min of exploratory 
behavior within the maze. 
 Acquisition.  Following the habituation sessions, acquisition training began.  Ten 
sessions were carried out daily.  Within each session, there were two phases: the forced-
trial and the choice-trial.  During the forced-trial, one arm of the maze was closed, the 
other left opened and baited with a quarter of a Froot Loop.  The rat was placed in the 
start arm and allowed to enter the open arm and consume the reward.  Immediately after 
consuming the reward, the rat was removed from the maze and placed in a yellow bucket 
with a white cover that was placed on the ground next to the maze for approximately 5 
sec.   During the choice-trial, the opposite arm was baited and both arms were open.  Rats 
had to remember the arm visited during the forced-trial in order to correctly alternate 
during the choice-trial to obtain the food reward.  The baited arm was randomly assigned 
to either the right or left arm for no more than three successive right or left designations 
per session.  Once the rat performed 9/10 correct trials for three consecutive days, they 
were considered to have met criteria for testing.    
Testing.  The day after criterion had been met, rats underwent the testing which 
followed the training protocol described above, except three delays (5, 15, and 20 min) 
were introduced between the forced and choice phases of each of the ten daily trials.  
Twenty-one days following the last test, rats were again tested with a 20 min delay.  The 
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following day, rats received an i.p.  injection of 0.75 mg/kg amphetamine 20 min prior to 
the forced phase and were tested in the choice phase after a 5 min delay. 
 Social interaction.  The social interaction test was performed in a square open-
field box made of wood (123 x 123 x 46 cm) placed directly on the ground.  The floor 
was covered with wood chip bedding and a web camera was positioned above the arena 
in order to record the sessions for later analysis. 
 Adult male rats were paired with an unfamiliar rat from the same treatment 
condition (nMK = 8; nSAL = 8) matched for body weight (within 15 g).  All rats were 
habituated to the test environment and arena prior to the test day.  Habituation consisted 
of placing each rat in the arena for 10 min on two consecutive days.  On test day, pairs of 
rats were placed in the test arena together for 10 min.  Behaviour during test day was 
recorded for subsequent scoring with ODLog version 2.7.2 (Macropad, software).  The 
following four parameters were scored: (1) following (rat moves after the conspecific 
around the arena); (2) sniffing (sniffing the conspecific's snout or parts of the body 
including the anogenital region); (3) mounting (climbing over the conspecific's back); 
and (4) wrestling (fighting with the conspecific).   
 Sucrose preference.  Anhedonia-like behaviour was assessed in adult male rats 
(nMK = 10; nSAL = 10) using the sucrose preference test under water-restricted conditions 
and under non-restricted conditions.  Under both conditions, rats were tested with a 1% 
and a 5% sucrose solution, the order of which was counterbalanced. 
 Water restricted condition.  Rats were water restricted and given access to two 
identical bottles of tap water from 9:00 to 9:15 and 17:00 to 17:45 for 5 days.  Water 
consumption was recorded every morning following the 15 min water access by 
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reweighing preweighed bottles to ensure that the rats were drinking during this period 
and were not showing a preference for the right or left bottle.  All sucrose preference tests 
took place at 9:00 and the bottles were reweighed at 9:15.  The side on which the bottle 
of sucrose solution was placed was counterbalanced.  The first test took place the day 
after the 5 days of water restriction.  Half the rats were given access to a bottle of tap 
water and a bottle of 1% sucrose solution while the other half were given a bottle of tap 
water and a bottle of 5% sucrose solution.  The following day, rats that had previously 
been given access to 1% sucrose were now given 5% sucrose and vice versa.   
 Non-Restricted Condition.  Rats were given free access to two bottles of water 
for the remainder of the experiment.  Under non-water restricted conditions, rats were 
again presented with a bottle of either 1% or 5% sucrose solution (counterbalanced) and a 
bottle of tap water for a period of 4 hours (9:00 to 13:00).  The preweighed bottles were 
reweighed after 15 min and 4 hrs.  The percent sucrose preference was calculated using 
the following formula: Sucrose preference = sucrose consumption/(water consumption + 
sucrose consumption) x 100%.   
 Set-shifting.  Cognitive flexibility was assessed in adult male rats (nMK = 8; nSAL 
= 7) using a plus-maze based set-shifting procedure.  The plus-maze walls extended 28 
cm above a wire grid flooring which measured 10.5 cm in width.  The roof of the maze 
was transparent.  Four arms were arranged at 90° angles around a 14 x14 cm central 
chamber and measured 75 cm in length.  Black polyurethane guillotine doors were used 
to open or close the entrance to the maze and to the goal arms from the central chamber.  
At the end of each arm was a metal food recipient.  One of the arms was paneled with 
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white plastic serving as a visual cue.  The task was divided into four phases: habituation, 
turn bias procedure, pre-shift training, and post-shift training.   
Habituation.   On day 1, three Froot Loops were placed in each arm with two 
pieces in the food well at the end of the arm.   Rats were allowed to move freely in the 
maze for 15 min.  If all 12 Froot Loops were eaten in less than 15 min, it was placed in a 
yellow holding bucket while the arms were re-baited before it was placed back into the 
maze for the remaining time.  On day 2, the same procedure as day 1 was repeated, 
however, when the rat ate two Froot Loops, it was removed from the maze and placed 
into another arm.   This was done in an effort to acclimatize the rats to being handled 
after eating the cereal reward.  The subsequent habituatation sessions were the same as on 
day 2 except only two half loops were placed in the food wells only.  This procedure 
continued daily until the rat consumed the rewards from all food wells for four trials.   
One trial consisted of the rat consuming all the rewards in every arm. 
Turn-bias.  Once habituation was complete, rats were tested to establish their turn 
bias.  The maze was turned into a t-maze by blocking off one of the arms.   The rat was 
placed at the beginning of the start arm and allowed to turn left or right to obtain a half 
Froot Loop from the food well at the end of the arm (both arms were baited).   Once the 
rat turned and consumed the reward, it was picked up, placed in the same start arm, and 
allowed to make another choice of arm.  If the rat chose the same initial arm, it was 
returned to the starting arm until it chose the opposite arm from its initial choice and ate 
the cereal.   After choosing both arms, the rat was returned to the yellow holding bucket, 
the block and visual cue were moved to different arms and a new trial began.   The turn 
bias trial consisted of entering both choice arms and consuming the cereal for a total of 7 
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trials.   Each initial turn was recorded and summed up at the end of the 7 trials to provide 
a turn-bias (4 or more turns in the same direction out of 7).   This turn bias was later used 
for the response-discrimination testing where the rat was trained to turn the opposite 
direction of its turn bias. 
 Response-Visual-Cue Testing.  The task was separated into two phases: pre-shift 
and post shift.  In each phase, rats had to learn a different rule which was 
counterbalanced.  In both phases, the rat started from one of the arms designated west, 
south, or east.   One of the arms had white paneling which served as a visual cue and was 
placed in different arms pseudo-randomly.   For every consecutive set of 12 trials, the 
visual cue appeared an equal number of times in each arm.   During the pre-shift phase, 
the rats had to either learn response or visual-cue discrimination (counterbalanced).  For 
response discrimination, the rat was placed in a starting arm (never north) and had to 
learn to turn in the opposite direction of its turn-bias in order to reach the food well with a 
half-piece of Froot Loops.  For visual-cue discrimination, the rat had to learn to turn into 
the arm with the visual cue to obtain the reward (acquisition).   This procedure was 
repeated for 24 trials daily until the rats successfully achieved 10 consecutive trials.   
Once this was achieved, the rat was tested in a probe phase, where the rat started from the 
north arm, which had never used before to avoid possible visual cues in the room.   If the 
rat correctly turned in the same direction as on testing, the pre-shift phase was completed.   
However, if the rat made an incorrect turn, training continued as described above until the 
rat made 5 consecutive correct choices at which point another probe trial was 
administered.   This procedure continued until the probe was successfully completed.   
Once the pre-shift phase was completed, the post-shift phase began.  In the post-shift 
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phase, rats had to ignore the previously relevant rule in order to acquire a new rule.  Rats 
that had previously been trained in response discrimination were now trained on visual 
cue discrimination and vice versa.   The same procedure as described above was 
implemented here where the rat had to achieve 10 correct trials consecutively and a final 
probe.   The procedure is based on Ragozzino (2001) (Figure 12).    
 High performance liquid chromatography.  Concentrations of DA, 3,4-
dihydroxyphnylacetic acid (DOPAC) and homovanillic acid (HVA) were measured by 
electrochemical detection.   
 Tissue preparation.  Adult male rats (nMK = 8; nSAL = 7) received an i.p.  injection 
of 0.75 mg/kg amphetamine.  Twenty min after injection, rats were decapitated without 
anesthesia and their brains were removed and immersed in 2-methylbutane, chilled with 
dry ice, for 15 s and stored at -80˚C.  Bilateral tissue punches of 1 mm diameter were 
excised from 1.5 mm thick coronal slices (Figure 13).  Six punches from each hemisphere 
were taken for the nucleus accumbens (NAcc), dorsal lateral striatum (dlSTR), and dorsal 
medial striatum (dmSTR).  Three punches from each hemisphere were taken for the 
ventral prefrontal cortex (vPFC).  Filtered 0.1 M phosphate buffer was added to the tissue 
(100 μl) and the sample was vortexed for 30 s and re-frozen at -80 °C. 
One day before conducting high-performance liquid chromatography 
(HPLC), tissue samples were left to thaw for 1 hr on ice, vortexed for 30 s, and then 
centrifuged at 12,000 rpm for 10 min at 4 °C.  The supernatant was separated from the 
protein pellets and filtered (0.45μm).  Both the supernatant and the protein pellets were 





Figure 12.  Maze-based set-shifting task.  A) Response discrimination, B) Visual-cue 











+ 3.24 mm (vPFC) 
                         + 1.56 mm (NAcc) 
                                                        
                                                                         + 1.20 mm (dmSTR & dlSTR) 
Figure 13.  Location of tissue of tissue punches.  Bilateral tissue punches of 1 mm 
diameter were excised from 1.5 mm thick coronal slices.   
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HPLC.  DA and its metabolites were separated from other chemical species 
in the dialysate samples using HPLC and quantified using electrochemical detection (ED) 
as described in (Hernandez, Rajabi, Stewart, Arvanitogiannis, & Shizgal, 2008).  
Dialysate samples were loaded through manual injection ports (Rheodyne 7125; 
Rheodyne LLC, Rhonert Park, CA; 20µl loop) into a reverse-phase column (15cm × 
0.46cm Spherisorb-ODS, 5µm; Higgins Analytical, Mountain View, CA).  Following 
separation in the column the sample passed through dual-channel ESA (Chelmsford, MA) 
coulometric detectors (Coulochem 5100, with a model 5011 analytical cell), which were 
connected to a computer.  The detectors were set to reduce DA in one channel and to 
oxidize DA’s metabolites, DOPAC and HVA, in the other channel.  Standard samples of 
solutions containing known concentrations of DA and its metabolites were used to 
calibrate the equipment.  Waters 515 HPLC pumps (Lachine, Quebec, Canada) were used 
to circulate the mobile phase (19% acetonitrile, 40mg 0.076M SDS, 0.1M EDTA, 
0.058M NaPO4, 0.03M citric acid, pH 3.35) at a flow rate of 1.2mL/min.  EZChrom 
Chromatography Data System (Scientific Software Inc., San Ramon, CA) was used to 
analyze and integrate the data obtained for DA, DOPAC and HVA.   
 Protein quantification.  Protein pellets were left to thaw for 1 hr on ice and 
150 μl of NaOH was added to each sample, then vortexed for 30 s.  Three microliters of 
the resulting solution were analyzed in duplicate from each sample using a microplate 
scanning spectrophotometer (FLUOstar Galaxy, BMG Labtechnologies) using the BCA 
Protein Assay Kit.  Concentrations were estimated by comparing those from a known 
standard, then taking the average of the duplicate samples. 
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 Drugs.  For prenatal treatment: MK-801 (Sigma-Aldrich) was dissolved in 0.9% 
saline to create a solution of 0.1 mg/kg.    For drug-induced locomotor activity: D-
Amphetamine sulfate (AMPH) and MK-801 (both from Sigma-Aldrich) were dissolved 
in 0.9% saline. 
Statistical Analysis 
 All statistical analyses were conducted using SPSS version 22 for Windows 
(IBM, Chicago, IL).  As described in Chapter 1, corrected degrees of freedom where used 
when assumptions of equality of variance were violated and effect sizes were computed 
for all tests.   
Novel Object Preference.  A one sample t-test was used to compare each group's 
investigation ratio to chance (0.5).  Prenatal treatment (SAL, MK) served as the 
independent variable while investigation ratio served as the dependent variable.  
Investigation ratios that were significantly above chance level indicated that rats 
displayed preference for the novel object, suggesting that rats recognized the familiar 
object. 
Drug-Induced Locomotor Activity.  Separate two-way mixed analyses of 
variance (ANOVA) were conducted for each dose, using prenatal treatment (SAL, MK) 
as the between-subject factor and time as the within-subject factor (18 x 5-min bins).   
The dependent variable was the total distance travelled (cm).   
Delayed Non-Match to Place.  A one sample t-test was used to compare each 
group's number of correct trials (out of 10 trials) to chance (5/10).  Prenatal treatment 
(SAL vs.  MK) served as the independent variable while correct trials served as the 
dependent variable.  Number of correct trials that were significantly above chance 
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indicated that rats remembered which arm they had previously entered before the delay 
and were able to use their working memory adequately to enter the opposite arm during 
the choice phase.   
 Social Interaction.  An independent samples t-test was used to compare prenatal  
treatment (SAL vs MK; independent variable) on the four following behaviours: 
following, sniffing, mounting, and wrestling.    
Sucrose Preference.  An independent samples t-test was used to compare 
prenatal  
conditions (SAL vs MK; independent variable) on total water consumption (tap water  
plus sucrose solution; dependent variable).  A one sample t-test was used to compare 
each  
group's percentage of sucrose preference to chance (50%).  Prenatal treatment (SAL vs.   
MK) served as the independent variable while percentage sucrose preference served as  
the dependent variable.  Percentage of sucrose preference significantly above 50%  
suggested that rats preferred the sweetened water to the tap water while absence of  
sucrose preference was interpreted as indicating anhedonia. 
Set-Shifting.  Independent samples t-tests were conducted to compare the MK 
group to the SAL group on the following measures: (1) acquisition (the number of trials 
required for the rat to reach its first probe test); (2) criterion (number of trials until the rat 
successfully completed the probe); (3) probes (number of probes completed until correct 
response on probe test); and (4) null trials (number of trials during which the rat did not 
move for 5 consecutive min).  These variables were analyzed for both the pre-shift and 
post-shift phases of the task.  In addition, independent samples t-tests were conducted to 
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compare both treatment conditions on errors committed during the post-shift phase.  
Errors included: (1) never-reinforced errors (rat follows neither of the rules learned 
during response or visual cue discrimination); (2) regressive errors (rats are assumed to 
have learned the new rule, however sporadically revert back to the previous rule); and (3) 
perseverative errors (rats continue to use the previously learned rule when the trial 
requires turning the opposite direction).  Perseverative errors were counted by dividing 
the trials into blocks of four trials and when the rat used the first acquired rule three times 
or more within one block, it was considered to be perseverative.  When the rats used the 
first rule less than three times out of four within one block, the errors were counted as 
regressive.    
 High performance liquid chromatography.  An independent samples t-test was  
used to compare prenatal treatment (SAL vs MK; independent variable) on DA turnover 
in the NAcc, dmSTR, dlSTR, and vPFC.   
Results 
Maternal behaviour and pup weights 
 There were no statistically significant differences between MK-801- and saline-
treated dams on any of the five assessed maternal behaviours (Figure 14).  Thus, the 
treatment condition did not affect the way in which dams cared for their offspring during 
the first 14 days of life.  Body weights of MK and SAL male offspring did not differ 
significantly at PND 2, 7, 14, and 21 (Figure 15 A).  However, MK female pups weighed 
significantly less compared to the SAL pups at PND 2, t(41) = 2.93, p = .006, g = 0.91, 
and 7, t(39) = 2.91, p = .006, g = 0.91.  There were no statistically significant weight 






Figure 14.  Mean (± SEM) percentage of number of times Saline and MK-801 dams 
engaged in maternal behaviours.  From GD 7 to 19, dams received daily subcutaneous 
injections of either 0.9% saline or 0.1 mg/kg MK-801.  Refer to text for detailed 
























































Figure 15.  Mean (± SEM) body weights of (A) male and (B) female offspring from the 
Saline and MK-801 prenatal treatment groups at postnatal days 2, 7, 14, and 21.   * p < 





















































Novel object preference 
 Males 
 Juvenile.  As seen in figure 16 A, following a 90 sec delay, neither the SAL, t(8) 
= 0.10, p = .925, d = 0.03, or the MK rats, t(9) = 1.82, p = .103, d = 0.57, showed a 
statistically significant preference for the novel object.  However, following a 15 min 
delay, both the SAL, t(7) = 2.28, p = .056, d = 0.81, and the MK rats, t(8) = 2.46, p = 
.039, d = 0.82, showed a statistically significant preference for the novel object, 
suggesting that they recognized the familiar objects following this delay.  After a 4 hr 
delay, neither the SAL, t(8) = 0.47, p = .650, d = 0.16, or the MK rats, t(9) = 0.46, p = 
.657, d = 0.14, showed a statistically significant preference for the novel object, 
suggesting that rats were unable to recognize the familiar object following the longer 
delay.   
 Adults.  As seen in Figure 16 B, following a 15 min delay, both the SAL, t(8) = 
3.24, p = .012, d = 1.08, and the MK rats, t(10) = 2.90, p = .016, d = 0.57, showed 
statistically significant preference for the novel object.  After a 90 min delay, the SAL 
rats again showed statistically significant preference for the novel object, t(8) = 2.90, p = 
.020, d = 0.97.  However, the MK rats did not show statistically significant preference at 
this delay, t(10) = 1.56, p = .150, d = 0.47, suggesting that they may not have recognized 
the familiar object.  Following a 4 hr delay, neither the SAL, t(8) = 0.33, p = .749, d = 
0.11, or the MK rats, t(10) = 0.82, p = .431, d = 0.25, showed statistically significant 









Figure 16.  Mean (±SEM) investigation ratio for the first minute of the novel object 
preference test sessions for (A) juvenile prenatal Saline and MK-801 and (B) adult 




































































Figure 17.  Mean (±SEM) investigation ratio for the first minute of the novel object 
preference test sessions for (A) juvenile prenatal Saline and MK-801 and (B) adult 
prenatal Saline and MK-801 female offspring.  *Significantly different from 0.5, p < 

























































 Juvenile.  As seen in figure 17 A, following a 90 sec delay, the SAL rats showed 
statistically significant preference for the novel object, t(5) = 2.98, p = .031, d = 1.21, 
while the MK rats did not, t(7) = 1.69, p = .135, d = 0.60.  Conversely, after a 15 min 
delay, the SAL rats did not show statistically significant preference for the novel object, 
t(3) = 0.30, p = .780, d = 0.15, while the MK rats did, t(7) = 9.74, p = .000, d = 3.44.  
Following a 4 hr delay, neither the SAL, t(5) = 0.02, p = .982, d = 0.01, or the MK rats, 
t(6) = 0.15, p = .886, d = 0.06, showed statistically significant preference for the novel 
object. 
 Adults.  As seen in Figure 17 B, following a 90 min delay, the SAL rats did not 
show statistically significant novel object preference, t(10) = 2.10, p = .062, d = 0.63, 
while the MK rats did, t(7) = 2.84, p = .025, d = 1.00.  Following a 4 h delay, neither the 
SAL , t(10) = 4.16, p = .686, d = 0.13, or MK rats, t(7) = 0.87, p = .413, d = 0.30, showed 
statistically significant preference for the novel object.   
Drug-induced locomotor activity 
 Juvenile males 
 MK-801-induced locomotor activity.   Following the saline injection (day 1), 
ambulatory locomotion significantly habituated over time F(17,238) = 15.19, p < .001, 
p
2 
= 0.52, but there was no statistically significant difference between prenatal treatment 
groups, F(1, 14) = 0.33, p =.573, p
2 
= 0.02 (Figure 18 A).  The time by prenatal 
treatment interaction was statistically significant, F(17, 238) = 4.07, p < .001, p
2 
= 0.23.  
The 0.1 mg/kg MK-801 challenge (day 2) induced a statistically significant increase in 
locomotor activity over time, F(17, 238) = 8.24, p < .001, p
2 










Figure 18.  Mean (±SEM) total distance travelled (cm) by juvenile prenatal Saline and 
MK-801 male rats following a (A) saline injection, (B) 0.1 mg/kg MK-801 injection, and 































































































was no statistically significant difference between prenatal treatment groups, F(1, 14) = 
0.27, p =.614, p
2 
= 0.02 and there was no significant time by prenatal treatment 
interaction, F(17, 238) = 0.50, p =.950, p
2 
= 0.04 (Figure 18 B).  The 0.2 mg/kg MK-
801 challenge (day 3) resulted in a statistically significant increase in locomotor activity 
over time, F(17, 238) = 17.78, p < .001, p
2 
= 0.56, but there was no statistically 
significant difference between prenatal treatment groups,  F(1, 14) = 0.04, p =.832, p
2 
= 
0.00 and no significant time by prenatal treatment interaction, F(17, 238) = 0.27, p 
=.840, p
2 
= 0.02 (Figure 18 C). 
Amphetamine-induced locomotor activity.  The 0.75 mg/kg amphetamine 
challenge (day 1) resulted in a statistically significant increase in locomotor activity over 
time, F(17, 238) = 23.7, p < .001, p
2 
= 0.63.  However, as with the MK-801 challenges, 
there was no statistically significant difference between prenatal treatment groups, F(1, 
14) = 0.48, p =.499, p
2 
= 0.03 and no significant time by prenatal treatment interaction, 
F(17, 238) = 0.57, p =.910, p
2 
= 0.04 (Figure 19 A).  The 1.0 mg/kg amphetamine 
challenge resulted in a statistically significant increase in locomotor activity over time, 
F(17, 238) = 7.34, p < .001, p
2 
= 0.34, but no statistically significant differences 
between groups,  F(1, 14) = 1.35, p =.265, p
2 
= 0.09, or significant time by treatment 
interactions, F(17, 238) = 0.37, p =.990, p
2 
= 0.03 (Figure 19 B). 
Adult males.   
MK-801-induced locomotor activity.  A similar pattern of results was observed in 
adult rats whereby locomotor activity significantly habituated following the saline 
injection, F(17, 238) = 9.05, p < .001, p
2 
= 0.40, but there was no statistically significant 
difference between prenatal treatment groups, F(1, 14) = 0.02, p =.962, p
2 








Figure 19.  Mean (±SEM) total distance travelled (cm) by juvenile prenatal Saline and 
MK-801 male rats following a (A) 0.75 mg/kg amphetamine injection and (B) 1.0 mg/kg 













































































Figure 20.  Mean (±SEM) total distance travelled (cm) by adult prenatal Saline and MK-
801 male rats following a (A) saline injection, (B) 0.1 mg/kg MK-801 injection, and (C) 
0.4 mg/kg MK-801 injection.  * p < 0.05.  
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no significant time by prenatal treatment interaction, F(17, 238) = 0.72, p =.780, p
2 
= 
0.05, (Figure 20 A).  The 0.1 mg/kg MK-801 challenge also resulted in a statistically 
significant increase in locomotor activity over time, F (17, 238) = 3.12, p < .001, p
2 
= 
0.18.  Importantly, MK rats displayed significantly lower locomotor activity post-
injection compared to SAL rats, prenatal treatment: F(1, 14) = 4.61, p =.050, p
2 
= 0.25.  
There was no statistically significant time by prenatal treatment interaction, F(17, 238) = 
1.35, p =.163, p
2 
= 0.09 (Figure 20 B).  The 0.4 mg/kg MK-801 challenge also induced a 
statistically significant increase in locomotor activity over time, F(17, 170) = 11.37, p < 
.001, p
2 
= 0.53.  As was the case with the low dose of MK-801, MK rats appeared to 
move less than SAL rats in response to a high dose of MK-801, though this difference 
was at trend-level only, prenatal treatment: F(1, 10) = 4.07, p =.071, p
2 
= 0.29.  There 
was no significant time by prenatal treatment interaction, F(17, 170) = 1.19, p =.278, p
2 
= 0.11 (Figure 20 C). 
Amphetamine-induced locomotor activity.  An injection of 0.75 mg/kg 
amphetamine resulted in a statistically significant increase in locomotor activity over 
time, F(17, 221) = 8.79, p < .001, p
2 
= 0.40.  However, there were no differences 
between MK and SAL rats in total distance travelled, prenatal treatment: F(1, 13) = 0.84, 
p =.377, p
2 
= 0.06 and no significant time by prenatal treatment interaction, F(17, 221) 
= 0.34, p =.994, p
2 
= 0.03 (Figure 21 A).  A 1.0 mg/kg amphetamine challenge resulted 
in significantly increased locomotor activity over time, F(17, 238) = 18.55, p < .001, p
2 
= 0.57.  Again, however, there was no statistically significant difference between 
treatment conditions, prenatal treatment: F(1, 14) = 0.88, p =.363, p
2 
= 0.06 or time by 
prenatal treatment interaction, F(17, 238) = 0.89, p =.587, p
2 










Figure 21.  Mean (±SEM) total distance travelled (cm) by adult prenatal Saline and MK-
801 male rats following a (A) 0.75 mg/kg amphetamine injection, (B) 1.0 mg/kg 



































































































Following visual inspection of our data, we decided to challenge the adult males with an 
additional higher dose of 1.5 mg/kg amphetamine.  In both prenatal treatment groups, rats 
displayed a statistically significant increase in locomotor activity over time following the 
injection, F(17, 238) = 13.73, p < .001, p
2 
= 0.50.  However, there were no statistically  
significant differences between MK and SAL rats, prenatal treatment: F(1, 14) = 2.13, p 
=.166, p
2 
= 0.13, and no significant time by prenatal treatment interaction , F(17, 238) = 
1.04, p =.416, p
2 
= 0.07 (Figure 21 C). 
Juvenile females 
 MK-801-induced locomotor activity.   Following the saline injection (day 1), 
ambulatory locomotion significantly habituated over time F(17, 221) = 5.73, p < .001, 
p
2 
= 0.31, but there was no statistically significant difference between the prenatal 
treatment groups, F(1, 13) = 0.08, p =.778, p
2 
= 0.00 (Figure 22 A).  There was no 
significant time by treatment interaction, F(17, 221) = 0.66, p =.842, p
2 
= 0.05.  The 0.1 
mg/kg MK-801 challenge induced a statistically significant increase in locomotor activity 
over time, F(17, 221) = 7.99, p < .001, p
2 
= 0.38.  However, there was no statistically 
significant difference between prenatal treatment groups, F(1, 13) = 0.04, p =.837, p
2 
= 
0.00 and there was no significant time by prenatal treatment interaction, F(17, 221) = 
0.35, p =.993, p
2 
= 0.03 (Figure 22 B).  The 0.2 mg/kg MK-801 challenge resulted in a 
statistically significant increase in locomotor activity over time, F(17, 221) = 15.76, p < 
.001, p
2 
= 0.55, but there was no statistically significant difference between prenatal 
treatment groups,  F(1, 13) = 0.01, p =.924, p
2 
= 0.00 and no significant time by 
prenatal treatment interaction, F(17, 221) = 0.22, p =.1.00, p
2 










Figure 22.  Mean (±SEM) total distance travelled (cm) by juvenile prenatal Saline and 
MK-801 female rats following a (A) saline injection, (B) 0.1 mg/kg MK-801 injection, 




































































































Amphetamine-induced locomotor activity.  Challenge with a 0.75 mg/kg 
amphetamine dose resulted in a statistically significant increase in locomotor activity 
over time, F(17, 221) = 21.73, p < .001, p
2 
= 0.63.  However, as with the MK-801 
challenges, there was no statistically significant difference between prenatal treatment 
groups, F(1, 13) = 0.21, p =.656, p
2 
= 0.02 and no significant time by prenatal treatment  
interaction, F(17, 221) = 76, p =.742, p
2 
= 0.06 (Figure 23 A).  A 1.0 mg/kg 
amphetamine challenge resulted in a statistically significant increase in locomotor 
activity over time, F(17, 221) = 7.80, p < .001, p
2 
= 0.38, but no statistically significant 
differences between prenatal treatment groups,  F(1, 13) = 0.02, p =.895, p
2 
= 0.00, or 
significant time by prenatal treatment interactions, F(17, 221) = 0.86, p =.625, p
2 
= 0.38 
(Figure 23 B). 
Adult females.   
MK-801-induced locomotor activity.  As was the case in juvenile female rats, 
adult rat’s locomotor activity significantly habituated following the saline injection, F(17, 
238) = 9.94, p < .001, p
2 
= 0.42, but there was no statistically significant difference 
between prenatal treatment groups, F(1, 14) = 0.02, p =.891, p
2 
 <  0.001, and no 
significant time by prenatal treatment interaction, F(17, 238) = 0.96, p =.500, p
2 
= 0.06 
(Figure 24 A).  The 0.05 mg/kg MK-801challenge resulted in a statistically significant 
increase in locomotor activity over time, F(17, 221) = 8.72, p < .001, p
2 
= 0.40.  There 
was no statistically significant difference between prenatal treatment groups, F(1, 13) = 
1.01, p =.333, p
2 
= 0.07, or time by prenatal treatment interaction, F(17, 221) = 0.93, p 
=.544, p
2 
= 0.07 (Figure 24 B).  The 0.1 mg/kg MK-801 challenge also induced a 








Figure 23.  Mean (±SEM) total distance travelled (cm) by juvenile prenatal Saline and 
MK-801 female rats following a (A) 0.75 mg/kg amphetamine injection and (B) 1.0 















































































Figure 24.  Mean (±SEM) total distance travelled (cm) by adult prenatal Saline and MK-
801 female rats following a (A) saline injection, (B) 0.05 mg/kg MK-801 injection, and 


































































































= 08.  There was no statistically significant difference between prenatal 
treatment groups, F(1, 14) = 2.02, p =.660, p
2 
= 0.02, or time by prenatal treatment 
interaction, F(17, 238) = 0.448, p =.972, p
2 
= 0.03 (Figure 24 C).   
Amphetamine-induced locomotor activity.  Locomotor activity significantly 
habituated following the saline injection, F(17, 238) = 6.96, p < .001, p
2 
= 0.33, but  
there was no statistically significant difference between prenatal treatment groups, F(1, 
14) = 0.07, p =.794, p
2 
 <  0.001, and no significant time by prenatal treatment 
interaction, F(17, 238) = 0.47, p =.964, p
2 
= 0.03 (Figure 25 A).  An injection of 0.75 
mg/kg amphetamine resulted in a statistically significant increase in locomotor activity 
over time, F(17, 221) = 8.61, p < .001, p
2 
= 0.40.  However, there were no differences 
between MK and SAL rats in total distance travelled, prenatal treatment: F(1, 13) = 0.03, 
p =.377, p
2 
< 0.001 and no significant time by prenatal treatment interaction, F(17, 221) 
= 0.41, p =.982, p
2 
= 0.03 (Figure 25 B).  A 1.0 mg/kg amphetamine challenge resulted 
in significantly increased locomotor activity over time, F(17, 238) = 24.11, p < .001, p
2 
= 0.63.  Again, however, there was no statistically significant difference between prenatal 
treatment conditions, F(1, 14) = 0.28, p =.603, p
2 
= 0.02 or time by prenatal treatment 
interaction, F(17, 238) = 0.53, p =.934, p
2 
= 0.04 (Figure 25 C).      
Delayed Non-Match to Place Task 
 As seen in Figure 26, following a 5 min delay, both the SAL, t(6) = 4.86, p = 
.003, d = 1.84, and MK rats, t(7) = 5.92, p = .001, d = 2.09, performed significantly above 
chancel level suggesting that the maternal manipulation did not induce working memory 
deficits at this delay.  The 15 min delay also failed to induce deficits in SAL, t(6) = 3.87, 










Figure 25.  Mean (±SEM) total distance travelled (cm) by adult prenatal Saline and MK-
801 female rats following a (A) saline injection, (B) 0.75 mg/kg amphetamine injection 

































































































Figure 26.  Mean (±SEM) correct trials for adult prenatal Saline and MK-801 rats in the 
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following a 20 min delay where both SAL, t(6) = 5.05, p = .002, d = 1.91, and MK rats, 
t(7) = 4.95, p = .002, d = 1.75, continued to perform significantly above chance level.  
Twenty-one days later, rats were retested following a 15 min delay and both SAL, t(7) = 
3.27, p = .014, d = 1.16, and MK rats, t(5) = 2.60, p = .048, d = 1.06, performed above 
chance level.  When rats were tested with a 5 min delay following a 0.75 mg/kg 
amphetamine injection, SAL rats, t(7) = 1.99, p = .087, d = 0.70, did not perform above 
chance level suggesting that the drug challenge impaired working memory.  However, 
MK rats continued to perform above chance level following this same drug challenge, 
t(5) = 2.91, p = .034, d = 1.19.   
Social Interaction 
 As depicted in Figure 27, MK rats spent less time sniffing the conspecific 
compared to SAL rats.  This difference did not reach statistical significance, t(14) = 1.19, 
p = .254, but was supported by a large effect size (g =1.70).  Interestingly, MK rats spent 
more time wrestling the conspecific compared to SAL rats, though this difference was 
again not statistically significant, t(14) = 1.38, p = .190, g = 1.90.  There were no 
statistically significant group differences in time spent following, t(14) = 0.19, p = .854, g 
=0.26, or mounting the conspecific, t(14) = 0.48, p = .640, g =0.66.   
Sucrose Preference 
 There were no statistically significant differences between SAL and MK rats in 
total fluid consumption (tap water plus sucrose solution) on any of the 6 tests (Figure 28).   
 Water restricted tests.  As seen in Figure 29 A, during 15 min access to the 1% 
sucrose solution under water-restricted conditions, MK rats preferred the sucrose solution 






Figure 27.  Mean (±SEM) time spent engaged in social behaviour during the 10 minute 

















































Figure 28.  Mean (±SEM) total fluid consumption during sucrose preference tests in the 
adult prenatal Saline and MK-801 groups under (A) water-restricted conditions and (B) 
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Figure 29.  Mean (±SEM) percentage sucrose preference during sucrose preference tests 
under (A) water-restricted conditions and (B) non-restricted conditions in the adult 










































1% - 15 min 
access 
1% - 4 h 
access 
5% - 15 min 
access 


























statistically significant preference for the 1% sucrose solution, t(9) = 1.00, p = .342, d = 
0.32.  When tested with a 5% sucrose solution, neither the MK or SAL rats showed 
sucrose or tap water preference during a 15 min test under water-restricted conditions, 
MK: t(9) = 1.54, p = .159, d = 0.49; SAL: t(9) = 0.314, p = .761, d = 0.10 . 
 Non-restricted tests.  As seen in Figure 29 B, under non-restricted conditions, 
both the MK and SAL rats showed statistically significant preference for the 1% sucrose 
solution during the first 15 min, MK: t(9) = 3.41, p = .009, d = 1.08; SAL: t(9) = 2.48, p 
= .035, d = 0.79.  This preference was also observed in SAL and MK rats during a 4 hr 
test, MK: t(9) = 8.26, p = .000, d = 2.61; SAL: t(9) = 2.33, p = .045, d = 0.74.  When 
tested with a 5% sucrose solution under non-restricted conditions, both the SAL and the 
MK rats preferred the sucrose solution over the tap water during the first 15 min, MK: 
t(9) = 10.63, p = .000, d = 3.36; SAL: t(9) = 8.725, p = .000, d = 2.76.  Interestingly, 
during the 4 h test, although the SAL rats continued to show significant preference for the 
sucrose solution, t(9) = 2.65, p = .026, d = 0.84, the MK rats did not show preference for 
the sucrose solution over the tap water, t(9) = 0.44, p = .674, d = 0.14.   
Set-Shifting 
Pre-shift trials.   
Acquisition.  There was no statistically significant difference in the number of 
trials required to reach the first probe test between SAL (M = 82.86, SD = 61.80) and MK 
rats (M = 83.75, SD = 57.03); t(13) = 0.03, p = .977, g = 0.02.   
Criterion.  There was no statistically significant difference in the number of trials 
performed until a correct response in the probe test was achieved between the SAL (M = 
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84.47, SD = 64.53) and the MK rats (M = 92.50, SD = 66.97); t(13) = 0.24, p = .816, g = 
0.12.   
Probe.  There was no statistically significant difference in the number of probe 
trials until a correct response was obtained between the SAL (M = 1.14, SD = 0.38) and 
the MK rats (M = 1.63, SD = 0.74); t(10.66) = 1.61, p =.136, g = 0.80. 
Null trials.  There was no statistically significant difference in the number of non-
completed trials between the SAL (M = 9.14, SD = 17.58) and the MK rats (M = 4.13, SD 
= 7.24); t(13) = 0.74, p = .471, g = 0.38. 
Taken together, these results suggest that prenatal exposure to MK-801 did not 
cause changes in the offspring's ability to learn and carry out the task. 
Post-shift trials.   
Acquisition.  As seen in Figure 30 A, MK rats required more trials to reach 
criterion compared to the SAL rats.  This difference did not reach statistical significance, 
t(9.33) = 1.44, p = .183, but visual inspection of figure 30 A as well as consideration of 
the effect size (g = 0.77) suggest that the MK rats experienced difficulty acquiring the 
new rule.    
Criterion.  Rats from the MK group required more trials until the criterion was 
reached compared to the SAL rats (Figure 30 A).  Again, this difference was not 
statistically significant, t(8.32) = 1.30, p =.229, but became apparent after visual 
inspection of Figure 30 A and a considerable effect size (g = 0.70).   
Probe.  There was no statistically significant difference in the number of probe 
trials between the SAL group and the MK group, t(9.57) = 1.36, p = .204, g = 0.67 







Figure 30.  Mean (±SEM) (A) number of trials and (B) number of errors during the post-
shift phase of the set-shifting task in the adult prenatal Saline and MK-801 groups.   






















































Null trials.  There was no statistically significant difference in the number of 
trials performed between the SAL group and the MK group, t(7.21) = 1.50, p =.177, g = 
0.72 (Figure 30 A).   
Errors.  As seen in figure 30 B, there was no statistically significant difference in 
the number of never-reinforced errors between the SAL group and the MK group , t(8.70) 
= 0.16, p =.878, g = 0.09.  There was no statistically significant difference in the number 
of perseverative errors between the SAL rats and the MK rats, t(13) = 0.04, p = .971, g = 
0.02.  Interestingly, the MK rats made significantly more regressive errors compared to 
the SAL rats, t(13) = 2.47, p = .028, g =1.20.  This difference suggests that MK rats 
experienced difficulty maintaining a newly acquired rule and had the tendency to revert 
back to the previous rule.   
Dopamine/DOPAC ratio  
 As seen in Figure 31, although no between-group differences reached statistical 
significance, medium effect sizes suggested that DA turnover appeared to be lower in 
MK rats compared to SAL rats in the NAcc, t(10.11) = 1.40, p = .193, g = 0.70, dmSTR, 
t(7.86) = 1.60, p = .149, g =0.80, and vPFC, t(14) = 1.40, p = .185, g =0.70, following a 
0.75 mg/kg amphetamine injection.  The difference did not appear to be as large in the 
dlSTR, t(13) = 0.90, p = .387, g =0.46. 
Summary 
 No statistically significant differences were found between SAL and MK dams on 
any of the assessed maternal behaviours suggesting that treatment condition did not 
impact the way in which dams cared for their offspring during the first 14 days following 







Figure 31.  Mean (±SEM) DOPAC/DA ratio in the nucleus accumbens, dorsal lateral 
striatum, dorsal medial striatum, and ventral prefrontal cortex in the adult prenatal Saline 

































SAL and MK offspring were not the result of differences in maternal care.  Our 
hypothesis that MK offspring would have lower weights compared to SAL offspring was 
not supported for the males, with no statistically significant differences found at PND 2,  
7, 14, or 21.  However, we found that MK females weighed significantly less than SAL 
females at PND 2.   
 Hypotheses regarding NOP in male rats were partially supported.  During the 
juvenile period, neither the SAL or MK rats showed statistically significant NOP 
following the 90 sec and 4 h delays, but both groups showed statistically significant NOP 
following a 15 min delay.  Interestingly, while both the SAL and MK adult males showed 
statistically significant NOP after a 15 min delay, NOP was only observed in the SAL 
rats following the 90 min delay, suggesting that prenatal MK-801 administration led to 
altered NOP following this delay.  Neither the SAL nor MK adult males showed 
statistically significant NOP following a 4 h delay suggesting that they may not have 
recognized the sample object after this longer delay.  A different pattern of results was 
observed with female rats.  Following a 90 sec delay, juvenile SAL females showed 
statistically significant NOP but the MK rats did not, while the exact opposite was 
observed following the 15 min delay.  Consistent with what was found with males, 
neither the SAL or MK juvenile females showed statistically significant NOP following a 
4 h delay.  In adulthood, MK females showed NOP following the 90 min delay while the 
SAL rats did not.  NOP was not observed in either of the groups following a 4 h delay.   
 Our hypotheses regarding AMPH and MK-801-induced locomotor activity in 
juvenile male rats were supported.  No statistically significant differences were found in 
locomotor activity between SAL and MK rats following any of the AMPH or MK-801 
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challenges.  In adult male rats, we found statistically significant differences between SAL 
and MK rats following the MK-801 challenges, but these differences were contrary to our 
hypotheses.  More specifically, we observed reduced responsiveness to MK-801 in the 
MK males compared to the SAL males.  No statistically significant differences were 
observed in response to the AMPH challenges.  As was the case with juvenile males, 
there were no differences between SAL and MK females in locomotor activity following 
any of the drug challenges during the juvenile period.  Contrary to our hypothesis, we did 
not observe any statistically significant differences between SAL and MK adult females 
following the MK-801 or AMPH challenges.   
 Our hypotheses about working memory were not supported.  More specifically, 
all adult male rats were successful in completing the delayed non-match to place task at 
all delays and no statistically significant differences between SAL and MK rats were 
observed.  These results suggest that prenatal MK-801 administration did not induce 
deficits in working memory as assessed with this task.   
 When assessing for differences in social behaviour in adult male offspring, we 
found that MK rats spent less time sniffing and more time wrestling the conspecific 
compared to SAL rats.  In line with our hypothesis, these results suggest a possible 
tendency for MK offspring to spend less time engaged in prosocial behaviours.  
However, we did not see any statistically significant differences between SAL and MK 
rats in time spent following and mounting the conspecific.   
 In the sucrose preference test, we hypothesized that MK rats would not show 
preference for sweetened water, indicating anhedonia-like behaviour.  This hypothesis 
was partially supported.  When rats were given 4 h access to a 5% sucrose solution under 
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ad libitum water and food conditions, adult male SAL rats showed statistically significant 
preference for the sweetened water while the MK rats did not.  This effect, however, was 
not observed during the first 15 min of the test, or when the rats were tested with a 1% 
sucrose solution.  Furthermore, when rats were tested with a 1% sucrose solution under 
food and water restriction conditions, MK rats showed statistically significant preference 
for the sweetened water while the SAL rats did not.  When tested under the same 
conditions with a 5% sucrose solution however, neither the SAL or MK rats showed 
statistically significant preference for the sweetened solution.   
 In the set-shifting task, we hypothesized that adult male MK rats would show an 
impaired ability to shift to a new rule.  More specifically, we expected to see more 
perseverative errors in MK rats compared to SAL rats.  These hypotheses were again 
only partially supported.  Consistent with our hypothesis, there were no statistically 
significant differences between SAL and MK rats in the pre-shift phase suggesting that 
prenatal MK-801 administration did not result in impaired ability to learn the task.  
However, during the post-shift phase, MK rats appeared to take more time to acquire the 
new behaviour.  Contrary to our hypothesis, we did not find differences between SAL 
and MK rats on number of perseverative errors committed.  Interestingly however, we 
found that MK rats made significantly more regressive errors than the SAL rats 
suggesting that MK rats experienced difficulty maintaining a newly acquired rule.   
 Finally, we hypothesized that adult male MK offspring would show enhanced DA 
activity following an injection of AMPH.  Although we did not observe any statistically 
significant differences, DA turnover appeared to be reduced in the NAcc, dmSTR, and 
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vPFC of MK rats compared to SAL rats, indicating that prenatal MK-801 administration 

























 The current thesis set out to investigate whether prenatal manipulations could 
induce behavioural and neurochemical changes that would be manifested in adult, but not 
juvenile male and female offspring.  The prenatal manipulation in Chapter 1 was based 
on the epidemiological relation between maternal infection and schizophrenia in humans 
and involved exposure of pregnant females to poly I:C, a viral mimic, at day 15 of 
gestation.  Behaviour was assessed in the juvenile and adult offspring of these dams.  In 
Chapter 2, we set out to explore the role of the NMDA receptor in subsequent 
neurodevelopment by exposing pregnant females to repeated administration of the 
NMDA receptor antagonist, MK-801.  A battery of tasks designed to assess positive, 
negative, and cognitive-like behaviours were used in the juvenile and adult offspring.   
Chapter 1: Behavioural consequences of prenatal immune challenge in the juvenile 
and adult rat offspring 
 Experiments in Chapter 1 aimed to replicate findings from numerous researchers 
suggesting that prenatal treatment with poly I:C induces deficits in cognitive tasks, 
attention deficits, and hypersensitivity to the locomotor activating effects of 
psychostimulant drugs.  Furthermore, we predicted that these behavioural alterations 
would be manifested in adult, but not juvenile offspring.  Our results did not support the 
hypothesis that maternal infection via prenatal poly I:C administration produces 
schizophrenia-like symptoms in adult offspring, thereby putting into question the 
robustness of this commonly used model.   
 Effects of poly I:C on maternal weight change and immune response.  
Maternal weight change has been proposed to serve as an indicator of the pregnant dam’s 
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individual immune response to the poly I:C challenge (Meyer & Feldon, 2012).  By 
administering exogenous cytokines to pregnant rats and mice, researchers have shown 
that elevated maternal cytokines, markers of the immune response, is sufficient in 
inducing behavioural effects in the offspring (Samuelsson et al., 2006; Smith et al., 
2007).   Thus, it has been proposed that the release of pro-inflammatory cytokines is the 
primary mechanism by which maternal poly I:C challenges induces its effects.   
Concomitantly, maternal weight loss is thought to serve as an index of the dam’s immune 
response.   
 In the present study, no weight loss was observed on the day following the poly 
I:C injection and there were no differences between SAL and poly I:C dams in weight 
change following the treatment.  It is thus possible that our prenatal challenge was not 
successful in evoking a maternal immune response that is thought to be crucial in 
inducing subsequent behavioural alterations in the offspring.  Indeed, this may explain 
why we were unable to show behavioural deficits in adult poly I:C offspring.  This 
potential explanation, however, assumes that maternal weight loss/change following poly 
I:C challenge does in fact reflect potency of the immune response which is in turn related 
to severity of the observed deficits in adult offspring.  However, the literature on the 
subject of maternal weight change is inconsistent and researchers have yet to reach a 
consensus. 
 Previous research has described a significant variability in the maternal body 
weight response to poly I:C injection.  According to Wolff and Bilkey (2010), however, 
maternal weight loss appears to be independent from the effect of maternal infection on 
foetal neurodevelopment.  More specifically, they found that prenatal poly I:C challenge 
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induced deficits in PPI of the acoustic startle response in adult offspring and that these 
deficits were not correlated with maternal weight loss on the day following the maternal 
manipulation.  These findings are contrary to previous reports of existing differences in 
behavioural outcome between offspring of dams that lost weight and offspring of dams 
that gained weight in a variety of behavioural tasks such as PPI, sensitivity to the 
locomotor-activating effects of DA agonists and NMDA receptor antagonists, and 
sucrose preference tests (Bronson, Ahlbrand, Horn, Kern, & Richtand, 2011; Vorhees et 
al., 2012).   
 A recent study by Missault et al.  (2014) found that dams that lost weight 
following poly I:C challenge, but not those that gained weight, showed increased levels 
of TNF-α compared to control dams.  Furthermore, offspring born to dams that had lost 
weight showed the most severe behavioural outcome while offspring born to poly I:C-
treated dams that did not lose weight did not show clear behavioural deficits.  
Interestingly, they did see an effect for maternal weight loss on PPI in adult offspring.  
These mixed findings suggest that although there may be an association between 
maternal weight loss and subsequent behavioural deficits in the offspring, this association 
is complex and may be limited to specific behavioural tasks.  In the context of our study, 
it is possible that the absence of a strong immune response, as indexed by the absence of 
maternal weight loss following the poly I:C injection, may explain our null findings.   
 One major limitation in our study was our failure to monitor the pregnant 
female’s immune response following the poly I:C injection.  Given the literature that 
seems to indicate a possible role for maternal weight loss/change following the maternal 
treatment, future studies should aim to follow the dam’s febrile response more closely by 
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either weighing the females throughout gestation, monitoring changes in body 
temperature that would indicate febrile response, or collecting blood following the 
treatment in order to quantify the presence of important pro-inflammatory cytokines.  
Researchers may also wish to keep track of which offspring came from high immune 
response dams versus those born to low immune response dams in an attempt to, on one 
hand, evaluate the association between maternal immune response and behavioural 
impairment in the offspring and, on the other hand, to optimize their chances of seeing an 
effect if one is present.    
 Another important consideration that is generally not discussed in published 
articles describing the effects of maternal infection is that there are batch and lot 
variations in the pyrogenic and cytokinogenic activity of commercial poly I:C (L.  
Harvey & Boksa, 2012).  In an effort to facilitate comparisons and replication, 
researchers are encouraged to carefully select dosages and routes of administration of 
poly I:C based on pilot studies with their own batches of poly I:C rather than relying on 
published studies that were carried out with different batches.  In the present study, 
although we chose to not collect blood samples from our pregnant dams in an effort to 
reduce the risk of stress as a confound variable, we attempted to control for this limitation 
by conducting a pilot study.  Non-pregnant female rats were injected with saline or poly 
I:C from two separate batches and of two different doses and plasma was assayed for IL-
6, in order to make sure that cytokine titers are within the range reported in the literature.  
Nevertheless, because we did not quantify levels of IL-6 in our experimental dams, we 
cannot conclude with absolute confidence that IL-6 levels following our poly I:C 
injections were at a desired level.   
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 Reports of individual variations in immune response as well as differences in 
batches of poly I:C illustrate that successful replication of poly I:C studies is all but 
trivial.  In fact, the effects of this early manipulation are highly dependent on a number of 
complex factors that need to be carefully controlled.   
 Effects of poly I:C on NOP in juvenile and adult offspring.  As previously 
discussed, patients with schizophrenia often present with impaired object recognition 
memory.  Previous researchers that have used poly I:C to model maternal infection in 
rodents have shown alterations in NOP in adult, but not juvenile, offspring (W.  Y.  Li, 
Chang, Lee, & Lee, 2014; Lukasz et al., 2013; Ozawa et al., 2006).  Thus, our first goal 
was to examine whether adult, but not juvenile, rats born to poly I:C treated dams would 
exhibit alterations in novel object preference following a series of delays.  Our results 
from adult male rats show that both SAL and poly I:C offspring showed novel object 
preference following a 90 sec and 15 min delay, suggesting that prenatal infection did not 
result in differences in object recognition memory following these delays.  Interestingly, 
neither the SAL nor poly I:C rats showed NOP at the longer 4 h delay, suggesting that 
they were unable to recognize the familiar object.  In contrast to our hypothesis, however, 
this absence of novelty preference was not limited to the poly I:C rats suggesting that the 
rats failed to recognize the novel object due to difficulties unrelated to prenatal infection, 
as detained below.  Interestingly, results from adult females were more in line with our 
hypothesis.  Although both the SAL and poly I:C adult females showed NOP at the 90 
sec and 15 min delays, poly I:C females no longer showed NOP following the 4 h delay 
while SAL females did.  This suggests that prenatal exposure to poly I:C induced a deficit 
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in object recognition in adult female offspring that was only observable following the 
longer 4 h retention period.   
 An important limitation of the NOP task is that its usefulness as a test of 
recognition memory is limited to situations in which rats display NOP that is significantly 
above chance (Gaskin et al., 2010).  In other words, when rats show statistically 
significant NOP, one can safely infer that the rats are able to recognize the familiar 
object.  However, a lack of NOP may not necessarily indicate an impairment in the 
retrieval of the representation of the familiar object, as manipulations aimed at increasing 
the familiarity of the sample object (e.g. increasing time of familiarization phase) had no 
effect on the preference for the novel object during the retention test (Gaskin et al., 2010).  
Therefore, caution should be used when drawing conclusions about the reason rats fail to 
display significant NOP, as this may not always be a reliable sign of recognition memory 
impairment.  With this in mind, it is possible that the absence of NOP following a 4 h 
delay in both the SAL and poly I:C adult male offspring does not imply that the rats did 
not recognize the sample object.  In fact, NOP has been documented in adult Sprague-
Dawley rats up to a 24 hour delay (Reger, Hovda, & Giza, 2009).  One possible 
explanation for the lack of NOP following a 4 hour delay is that the sequence of delays 
used was not counterbalanced – all rats were first tested with a 90 sec delay, followed by 
a 15 min delay, and finally the 4 h delay.  It is thus possible that rats were simply no 
longer interested in the task by the time they were tested with the longer delay.   
 The first and foremost hypothesis was that prenatal poly I:C would result in 
impaired NOP in adult rats.  Secondly, we hypothesized that this impairment would not 
be observed in juvenile offspring.  Because our adult hypothesis was not supported, 
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results from the juvenile rats are less relevant.  Nonetheless, our juvenile results were 
unexpected and may have important ramifications for future studies.  Since NOP was not 
detected in the saline-treated group in any of the tested delays, we were unable to directly 
test the secondary hypothesis.  Rather, we observed that although poly I:C male offspring 
showed NOP following a 90 sec delay, the SAL rats did not.  The difference in sample 
size between the SAL and poly I:C rats may partly explain why the difference was 
statistically significant for one group but not for the other.  However, the small effect size 
for the SAL rats (d = 0.46) relative to that of the poly I:C rats (d  = 1.12) suggests that 
this was not the case.  Nevertheless, because our control group failed to show NOP at 
such a short delay, and neither the SAL or poly I:C rats showed NOP after the 15 min and 
4 h delays, interpretation of this apparent enhancement of NOP should be made with 
caution.  Finally, in female juvenile offspring neither the SAL or poly I:C rats showed 
NOP at any of the delays used.   
 Although the NOP test has been used to assess object recognition memory in 
adult rats born to poly I:C-treated dams, no researchers, to my knowledge, have used the 
task to assess the impact of prenatal poly I:C treatment on object recognition memory in 
juvenile offspring.  There have been reports showing that rats aged from PND 18 to PND 
31 have the ability to perform the NOP task with delays ranging from 1 min to 1 h 
between familiarization and test phase (Ainge & Langston, 2012; Anderson et al., 2004; 
Heyser & Ferris, 2013; Kruger, Brockmann, Salamon, Ittrich, & Hanganu-Opatz, 2012).  
Thus, it appears that the shorter delays used in the present experiment (90 sec and 15 
min) were within the range that would allow expression of NOP in juvenile rats.  In 
contrast, Anderson et al.  (2004) report a significant impairment in NOP in juvenile rats 
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following a 120 min delay which may suggests that our use of a 4 h delay with juvenile 
rats may have been too ambitious.    
 Another potential explanation as to why NOP in juvenile rats was not observed in 
the present experiment is that the rats used in the experiments described in Chapter 1 
were of the Wistar strain as opposed to Long-Evans rats that are more commonly used in 
behavioural experiments assessing memory.  However, this explanation does not appear 
to be satisfying as NOP has been reported not only in juvenile Long-Evans (Anderson et 
al., 2004), but also in Sprague-Dawley (Heyser & Ferris, 2013) and Wistar rats (Kruger et 
al., 2012).   
 Another important consideration is that the apparatus used to test NOP in juvenile 
rats was the same square arena that has been optimized to test NOP in adult rats in our 
facility.  Furthermore, although all pairs of objects used had previously been tested for 
the lack of innate preference in adult rats, they had not been tested with juvenile rats.  
Thus, it is possible that the use of an arena adapted for juvenile rats as well as objects 
pre-assessed for preference in juvenile rats may have yielded different results.  Indeed, 
Heyser and Ferris (2012) report that PND 21 rats tested in a square arena, as was used in 
the present experiment, spent a significant amount of time in the corners which lead to 
increased between-subject variability and decreased performance in this task.  The 
authors report that using a circular arena with rats of the same age significantly increased 
object exploration and decreased variability, making it a well suited task for young rats.  
It should be noted, however, that despite the fact that juvenile rats may be more likely to 
spend more time investigating objects in a circular arena as opposed to a square arena, it 
has been proposed that the amount of time spent investigating during the familiarization 
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phase is not a predictor of later performance in the retention test (Gaskin et al., 2010).  In 
fact, Gaskin et al.  (2010) suggest that significant preference for the novel object may 
only occur if a minimal amount of 60 to 90 sec of object investigation during 
familiarization is achieved.  Beyond this minimal amount, however, additional sample 
object investigation does not appear to result in a significant increase in the magnitude of 
NOP.  In the present experiment, rats exploring less than 60 sec during familiarization 
were excluded from the analyses.   
 Effects of poly I:C on AMPH-induced locomotor activity in juvenile and 
adult offspring.  Unlike the cognitive and, to a certain extent, negative symptoms of 
schizophrenia, the positive symptoms represent a challenge as their subjective nature 
make them particularly difficult to model in animals.   As previously discussed, exposure 
to the DA agonist, AMPH, has been shown to exacerbate positive symptoms in patients 
with schizophrenia and to increase mesolimbic DA activity.  This can be modeled in 
rodents whereby an AMPH challenge increases mesolimbic DA activity and, 
consequently, enhances locomotor activity.  Hyperactivity responses to AMPH in rodents 
is frequently used as a behavioural assessment serving as an index of underlying 
dopaminergic activity.  Hypersensitivity to the locomotor-activating effects of AMPH  
has been repeatedly reported in adult offspring of both mice and rats born to poly I:C 
treated dams (Meyer, Nyffeler, Yee, et al., 2008; Ozawa et al., 2006; Smith et al., 2007; 
Vuillermot et al., 2010; Zuckerman & Weiner, 2005).  Furthermore, Zuckerman et al.  
(2003) showed that the emergence of increased sensitivity to the locomotor-stimulating 
effects of AMPH were only observed in adult offspring.   
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 Based on these findings, we hypothesized that rats born to poly I:C-treated dams 
would show enhanced locomotor activity following an injection of AMPH compared to 
SAL rats.  Furthermore, we predicted that this enhanced sensitivity would be observed in 
adult but not juvenile rats.  Our results do not support these hypotheses.  In fact, no 
differences were found between prenatal treatment conditions in adult male rats 
suggesting that prenatal exposure to poly I:C did not result in mesolimbic DA 
hyperactivity.  Interestingly, poly I:C adult females showed lower locomotor responses to 
the low dose of AMPH compared to the SAL adult females.   
 Our adult results were surprising given the overwhelming reports of AMPH 
hypersensitivity in poly I:C-treated offspring.  However, a close examination of the 
recent literature indicates that prenatal poly I:C administration may not induce AMPH 
hypersensitivity as robustly as earlier research seemed to suggest.  For instance, Vorhees 
et al.  (2012) found that exaggerated hyperactivity following an AMPH challenge was 
only observed in rats born to poly I:C treated-dams (8 mg/kg; GD 15) that had lost or 
gained the least weight following the treatment.  The effect was not observed in offspring 
born to dams that gained the most weight following poly I:C treatment (Vorhees et al., 
2012).  As previously discussed, it is possible that our prenatal manipulation simply did 
not induce the optimal immune response required to induce behavioural deficits in the 
offspring.  Yet another explanation is that maternal infection via prenatal poly I:C 
treatment does not induce DA hyperactivity.  In fact, a recent study found that adult rats 
born to poly I:C treated-dams (4 mg/kg; GD 15) showed decreased responsiveness to 
AMPH compared to SAL offspring, a finding that was also dependent on maternal post-
treatment weight change (Missault et al., 2014).  The authors concluded that the observed 
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decreased responsiveness reflects alterations in dopaminergic circuits.  This finding is 
consistent with the decreased responsiveness that was observed in our adult poly I:C 
females.  In addition to the reports of decreased sensitivity to AMPH, there have also 
been reports of decreased locomotor responding in poly I:C offspring following a 
challenge with the NMDA receptor antagonist, MK-801 (Howland, Cazakoff, & Zhang, 
2012; Missault et al., 2014; Vorhees et al., 2012) .  MK-801 is frequently reported to 
induce an increased locomotor response in poly I:C offspring and is thought to do so via 
downstream effects on DA resulting in increased striatal DA (Meyer, Nyffeler, Yee, et 
al., 2008; Zuckerman & Weiner, 2005).  Thus, although sensitivity to the locomotor-
activating effects of MK-801 was not assessed in this experiment, these controversial 
results are consistent with our findings and demonstrate that poly I:C-induced 
mesolimbic hyperactivity is not easily replicable.   
 Effects of poly I:C on PPI of acoustic startle response in juvenile offspring.  
The acoustic startle response is a cross-species, whole body skeletomuscular response to 
sudden loud acoustic stimuli which can be modulated by the presentation of a weak 
acoustic prepulse shortly before the startling stimulus (i.e.  PPI of the acoustic startle 
response).  Impairments in PPI of the acoustic startle response are thought to reflect 
deficits in sensorimotor gating.  As previously discussed, the impairments in 
sensorimotor gating observed in schizophrenia are thought to lead to excessive 
processing of irrelevant stimuli resulting in cognitive overload and disordered thinking.  
The ability to demonstrate a deficit in PPI is therefore considered to be a hallmark feature 
of animal models of schizophrenia-like symptoms.  While adult PPI deficits have been 
well documented, the timing of the onset of PPI impairments has not been examined as 
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thoroughly.  More specifically, researchers have effectively shown that poly I:C 
treatment at GD 9 in mice and 15 in rats effectively results in impaired PPI of the 
acoustic startle response in adult offspring (Ozawa et al., 2006; Smith et al., 2007; Wolff 
& Bilkey, 2010).  There is debate, however, about whether such deficits have a purely 
post-pubertal onset or whether they can also be manifested in juvenile offspring.  Thus, 
our goal was, firstly, to assess whether our prenatal poly I:C treatment would result in 
impaired PPI in adult offspring, and secondly, whether or not juvenile poly I:C offspring 
would exhibit impaired PPI.   
 For previously discussed reasons, we were unable to assess PPI in the adult rat 
offspring which is especially unfortunate given the conflicting results in the current 
literature.  Furthermore, not knowing whether or not the adult poly I:C rats would have 
exhibited a deficit in PPI greatly complicates the interpretation of our juvenile results.  
We found that neither male or female juvenile poly I:C offspring showed deficits in PPI 
of the acoustic startle response compared to SAL rats.  These findings can indicate 
several things.   
 On one hand, our results may be consistent with previous reports that prenatal 
poly I:C administration results in a post-pubertal, but not pre-pubertal emergence of PPI 
deficit in mice (Meyer, Nyffeler, Yee, et al., 2008; Ozawa et al., 2006; Vuillermot et al., 
2010).  This maturational delay is indicative of a progression of pathological symptoms 
from pre-pubertal to adult life, which is consistent with the post-pubertal onset of full-
blown psychotic behaviour in schizophrenia (Rapoport et al., 2005).  On the other hand, 
the literature using rats as subjects appears to be more convoluted.  While some 
researchers report no PPI deficits in adult poly I:C- offspring (Missault et al., 2014), 
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others report that prenatal poly I:C produces PPI deficits of the acoustic startle response 
in both juvenile and adult rats (Wolff & Bilkey, 2008, 2010).  According to this view, it 
is possible that the observed absence of PPI deficits in our study is indicative of technical 
faults in our prenatal manipulation.  For instance, given the arguably important effect of 
maternal weight gain in magnitude of deficits, some may argue that our inability to 
induce PPI deficits in the juvenile offspring indicates that our poly I:C injections did not 
induce the threshold maternal immune response required to produce behavioural deficits 
in the offspring.  This, however, seems unlikely, as there have been reports that PPI 
differs from other forms of behaviour in that it does not appear to be associated with 
maternal weight loss (Wolff & Bilkey, 2010).   
 Finally, when comparing our results to those of the literature, our small sample 
size should be considered a serious limitation.  For instance, with our male rats, we did 
not find a statistically significant main effect for prenatal treatment condition and, 
consistent with this, our effect size was small (p
2 
= 0.15).  Wolff and Bilkey (2008), 
however, report an effect for prenatal treatment in juvenile rats that was not statistically 
significant, but at trend level.  Interestingly, the effect size in their study was of the same 
magnitude as ours (p
2 
= 0.15).  Even more important is the fact that the statistically 
significant effect of prenatal treatment on PPI in adult rats reported by Wolff and Bilkey 
(2008) was also of a similar magnitude to their trend-level juvenile effect and our non-
significant effect in juvenile males (p
2 
= 0.14).  This suggests that an increase in sample 
size may very well have revealed a statistically significant effect for prenatal poly I:C in 
our juvenile male rats.  Unfortunately, without the adult data, our PPI results remain 
inconclusive.   
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 Concluding remarks.  Our overall results did not support the general hypothesis 
that prenatal infection would induce behavioural deficits in adult, but not juvenile 
offspring.  As described in detail above, there are many explanations as to why our 
prenatal manipulation failed to induce behavioural deficits that have been reported in 
previous research.  It is also possible that there is truth to our findings and that poly I:C 
does not in fact induce behavioural alterations in the offspring of treated dams.  Indeed, 
discussions with many scientists at different neuroscience conferences suggest that our 
findings are far from being unique.  Many researchers, including a past graduate student 
in our laboratory, have attempted and failed at replicating poly I:C findings.  
Unfortunately, given scientific journals’ biases towards statistically significant findings, 
these impressive amounts of null findings are filed away.  The important take-home 
message from the work presented in Chapter 1 of this thesis is that the poly I:C model of 
schizophrenia-like behaviours is far from being as robust as the literature seems to 
suggest.   
Chapter 2: Behavioural and neurochemical consequences of chronic prenatal MK-
801 administration in the juvenile and adult rat offspring 
 Experiments in Chapter 2 were designed to examine whether blockade of NMDA 
receptor during prenatal development would result in altered behaviour and 
neurochemistry in adult, but not juvenile offspring.  More specifically, we aimed to 
replicate unpublished findings from our collaborators (Madularu et al., unpublished) 
indicating that adult offspring born to MK-801-treated dams displayed deficits in object 
recognition memory and sensitivity to the effects of drug challenges.  Furthermore, we 
predicted that MK-801-treated offspring would show cognitive impairments, attentional 
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deficits, anhedonia-like symptoms, and altered DA activity.  Given the critical role of 
NMDA receptors in the establishment of normal neural networks in the developing brain, 
and consistent with the early adulthood onset of symptoms in schizophrenia, we 
hypothesized that these deficits would have a post-pubertal emergence.  Although our 
findings do not support the conceptualization of prenatal MK-801 as a model of 
schizophrenia-like behaviours, our results suggest that prenatal NMDA receptor blockade 
induced changes in neurodevelopment that resulted in clear deficits in adult offspring. 
 Effects of prenatal MK-801 on body weight during development.  In order to 
confirm the effects of prenatal MK-801 administration on development, we observed the 
body weight of pups at various time points throughout development.  We did not find any 
differences between SAL and MK male pups at any of the time points.  However, we 
found the MK females weighed significantly less at PND 2 compared to SAL females of 
the same age.  This difference quickly disappeared with no body weight differences 
observed between SAL and MK rats at PND 7, 14, or 21.  These results are inconsistent 
with unpublished research from our collaborators that found that male MK offspring 
weighed significantly less than SAL offspring at PND 8.  In line with our findings 
however, Lu et al.  (2011) found no significant differences in body weight between rats 
born to PCP-treated dams and those born to SAL-treated dams.  Despite the absence of 
body weight differences, the prenatal PCP manipulation resulted in impaired NOP, 
increased immobility in a forced swim task, and attenuated glutamate transmission in the 
PFC (Lu et al., 2011).   These findings suggest that lower pup body weight as a result of 
prenatal PCP, and possibly MK-801, administration is not necessary to induce 
behavioural alterations in the adult offspring.    
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 Effects of prenatal MK-801 on novel object preference in juvenile and adult 
offspring.  As previously discussed, recognition memory has been shown to be disrupted 
in patients with schizophrenia.  In addition, researchers have shown an important role for 
glutamate in object recognition memory whereby NMDA receptor blockade via MK-801 
injections induces impairments in the NOP task at both short and long retention delays 
(Winters & Bussey, 2005).  Furthermore, in a previous study, Lu et al.  (2010) showed 
that prenatal exposure to the NMDA receptor antagonist, PCP, resulted in impaired object 
recognition memory following a 24 h retention delay in adult mice offspring.  Thus, we 
hypothesized that adult but not juvenile rats born to MK-801-treated dams would show 
impaired NOP.  This hypothesis was partially supported in adult male rats where SAL 
rats showed NOP following a 90 min delay while the MK rats did not.  This result 
suggests that prenatal NMDA receptor blockade induced neurodevelopmental changes 
that resulted in altered NOP in adult male offspring at this delay.   
 Consistent with our findings from Chapter 1, we were unable to observe NOP in 
either the SAL or MK adult males following a 4 h delay.  Curiously, this is inconsistent 
with previous findings of NOP in adult control Sprague-Dawley rats following up to a 24 
h delay (Reger et al., 2009).  Of course, NOP in this experiment was constrained by the 
same limitations discussed previously.  Briefly, interpretation of NOP results is limited to 
situations in which animals show NOP above chance level while a lack of NOP may not 
necessarily reflect impairment in object recognition.  Thus, it is likely that other factors, 
such as the failure to counterbalance retention delays, may explain why the rats failed to 
show NOP at a 4 h delay.  Interestingly, in an unpublished set of experiments, Madularu 
et al.  showed that SAL rats showed significant NOP following a 4 h delay when tested at 
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PND 60, while these same rats failed to show NOP following the same delay at PND 210.  
These results are consistent with the suggestion that NOP is age-dependent such that 
older rats are less likely to discriminate between familiar and novel objects (Scali et al., 
1997).  However, the rats in our study (approximately 3 months old) and Madularu et al.  
(7-8 months old) were considerably younger than the 24 months old rats used in Scali et 
al.’s study.  Thus, age-related performance deficits in the NOP cannot reliably explain the 
lack of NOP at the 4 h delay reported here.   
 As was the case with our poly I:C experiments, our predictions about NOP in 
juvenile offspring could not be supported.  We found that neither the SAL nor the MK 
juvenile male offspring showed NOP following 90 sec and 4 h delays.  To further 
complicate interpretation, both groups showed NOP at a 15 min delay.  The fact that 
NOP was observed at the 15 min delay, but not at the 90 sec delay suggests that factors 
other than impaired object recognition may explain our results.  As previously discussed, 
future studies examining NOP in juvenile rats should use objects previously tested for 
innate preference in juvenile rats and use a circular arena, as opposed to the square arena 
used here, to reduce time spent in corners (Heyser & Ferris, 2013).   
 The pattern of results for juvenile and adult females was complex.  Consistent 
with the male data and the results from our poly I:C experiments, we were unable to 
show NOP in adult female rats following a 4 h delay.  However, following a 90 min 
delay, MK females showed NOP while the SAL females did not.  Because we failed to 
observe the expected NOP in control rats after this delay, we cannot interpret results from 
the MK rats.  It should be noted that although NOP in female SAL rats was not 
statistically significant, the magnitude of the effect (d = .63) was comparable to that of 
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the MK adult males that reached statistical significance at a 15 min delay (d = .57).  
Considering effect size alone, this pattern of results suggests the prenatal MK-801 
treatment did not induce altered NOP in adult female offspring.  Juvenile female results, 
as was the case with male juvenile offspring, were inconclusive.   
 Effects of prenatal MK-801 on AMPH and MK-801-induced locomotor 
activity in juvenile and adult rat offspring.  As previously discussed, sensitivity to the 
locomotor activating effects of AMPH has become a hallmark phenomenon for animal 
models of schizophrenia-like behaviours and is thought to reflect mesolimbic DA 
hyperactivity which is associated with positive symptoms of schizophrenia.  Furthermore, 
induction of hyperlocomotoion via NMDA receptor antagonists, such as MK-801, is 
proposed to model the NMDA receptor-mediated hypoglutamatergic pathophysiology of 
schizophrenia (Javitt & Zukin, 1991).  We therefore hypothesized that adult offspring 
born to MK-801-treated dams would show increased locomotor activity following an 
AMPH and an MK-801 challenge compared to SAL offspring.  These hypotheses were 
not supported with the female data where we failed to observe any differences between 
SAL and MK offspring.  The male offspring data also did not support our hypothesis 
about sensitivity to AMPH.  Interestingly, we found that while there were no differences 
between groups during the juvenile period, adult male MK offspring showed reduced 
sensitivity to the locomotor-activating effects of MK-801.   
 This result was the exact opposite of what we had predicted – rather than 
displaying enhanced sensitivity to MK-801, as would be expected of an animal model of 
schizophrenia-like behaviour, we observed a marked reduction in MK-801-induced 
locomotor activity in MK offspring compared to control rats.  These results are 
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inconsistent with previous findings showing that prenatal exposure to MK-801 from E15-
18 in mice resulted in enhanced PCP-induced hyperlocomotion in adult offspring 
(Abekawa et al., 2007).  The authors propose that prenatal MK-801 administration 
disrupts GABAergic neurodevelopment in the medial PFC and that this disruption in 
GABA neurons development is related to the enhancement of the locomotor-activating 
effect of PCP that they observed.  Further research would be necessary to determine 
whether similar or opposite changes occurred using our protocol.  Interestingly however, 
our AMPH results are somewhat consistent with those of Abekawa et al.  (2007) who 
found no differences between MK and SAL rats in sensitivity to the locomotor-activating 
effects of psychostimulant drugs (in their case, methamphetamine).  The authors make 
the interesting proposition that psychostimulant-induced hyperactivity observed in other 
models can serve as a model of DA D2 receptor antagonist-responsive pathology 
(Abekawa et al., 2007).  Thus, perhaps our model that showed no AMPH-induced 
hyperactivity may model DA D2 receptor antagonist-resistant pathology.    
 It is possible that there was an age-dependent development of compensatory 
mechanisms that occurred in our rats to compensate for a loss of GABAergic neurons in 
the mPFC induced by prenatal MK-801 exposure.  Indeed, Madularu et al.  (unpublished) 
reported that PND 60 rats born to MK-801-treated dams showed increased locomotor 
activity following an MK-801 challenge.  Interestingly, in this same experiment, they 
found no differences between MK and SAL offspring in response to an MK-801 
challenge when rats were tested at PND 210.  Rats in the present experiment were 
between PND 150-170 at the time of these tests.  Thus, it is possible that we are 
witnessing age-dependent changes in response to drug challenges, which progressively 
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develops due to the compensatory mechanisms mentioned above.  Importantly, the 
sensitivity to the locomotor activating effects of PCP in prenatal MK-801 exposed rats 
was observed in PND 63 rats, (i.e., young adults) (Abekawa et al., 2007).  Future studies 
can attempt to shed light into these results by examining drug sensitivity in MK and SAL 
offspring at different stages of adulthood and combining these behavioural observations 
with molecular techniques that would allow testing for changes in GABAergic neurons.   
 As was previously discussed in the context of our poly I:C experiment, it is 
important to keep in mind that existing putative neurodevelopmental animal models of 
schizophrenia-like behaviours do not induce AMPH and MK-801 hypersensitivity as 
consistently as was once believed.  For instance, (Missault et al., 2014) found that 
prenatal poly I:C resulted in reduced responsiveness to AMPH in adult offspring.   
Consistent with our effects of prenatal MK-801 administration, several authors have 
reported decreased sensitivity to MK-801 in offspring born to poly I:C-treated dams 
(Howland et al., 2012; Missault et al., 2014; Vorhees et al., 2012).  Thus, it is unclear 
whether our results can be interpreted in the context of a schizophrenia model.  It is clear, 
however, that prenatal MK-801 disrupted normal brain development resulting in a post-
pubertal emergence of reduced sensitivity to MK-801.   
 Effects of prenatal MK-801 on working memory in a delayed-non-match to 
place task in adult male offspring.   Working memory, the ability to hold and 
manipulate information in order to perform various tasks (Baddeley & Della Sala, 1996), 
has been shown to be impaired in patients with schizophrenia (Green & Nuechterlein, 
2004).  Lesions of the ventral hippocampus in neonates has been shown to induce deficits 
in working memory (Lipska et al., 2002).  These findings suggest that interference with 
 122 
 
normal development in the circuitry of the hippocampus and the PFC induces working 
memory deficits that are consistent with findings in schizophrenia (Castner, Goldman-
Rakic, & Williams, 2004).  In addition, brief disruption of NMDA receptors via MK-801 
administration in rats on PND 7 through 10 (i.e.  equivalent to prenatal second trimester 
of primate brain development) resulted in impaired spatial working memory (Stefani & 
Moghaddam, 2005).  As working memory has yet to be assessed in a prenatal NMDA 
receptor blockade model, we tested whether prenatal MK-801 would induce working 
memory deficits in a T-maze based DNMP task in adult offspring.  We found no 
differences in working memory in SAL and MK rats following 5, 15, and 20 min delays.  
Thus, our findings suggest that prenatal MK-801 exposure does not induce working 
memory deficits, as measured with this task. 
 The absence of deficits in working memory again questions whether prenatal 
NMDA receptor blockade can be used as an animal model of schizophrenia-like 
behaviour.  An important consideration when examining working memory in the context 
of schizophrenia is the extent to which the rodent task used to assess working memory 
taps into the same process that is compromised in schizophrenia (Castner et al., 2004).  
Tasks that are designed to test working memory in rodents may also involve episodic 
memory, thereby recruiting the hippocampus, in addition to the PFC, especially when 
intervals are long (min vs.  sec) (Castner et al., 2004; Kesner & Rolls, 2001).  Thus, it is 
possible that given the long delays used in the present experiment, recruitment of the 
hippocampus may have compensated for any changes in PFC circuitry resulting from our 
prenatal manipulation.   
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 In an effort to maximize the probability of observing a deficit in working 
memory, we challenged the rats with AMPH prior to tests on the DNMP task with a 20 
min retention delay.  The rationale for this procedure was that if prenatal MK-801 had in 
fact induced changes in mesocorticolimbic DA circuitry, challenging this system with a 
DA agonist might help reveal a difference in working memory between the SAL and MK 
rats that is otherwise not apparent.  Furthermore, acute injections of high doses of AMPH 
have been shown to disrupt working memory in a delayed non-match to place task 
(Shoblock, Maisonneuve, & Glick, 2003).   However, no differences were observed 
between our two treatment conditions.  In retrospect, this result is not surprising given the 
fact that we did not observe differences between SAL and MK rats in sensitivity to the 
locomotor-activating effects of AMPH.  As we did see a between-group difference in 
sensitivity to MK-801, it would be interesting to test for working memory differences in 
SAL and MK offspring following the injection of an NMDA receptor antagonist.   
 Effects of prenatal MK-801 on social interaction in adult male offspring.   As 
previously discussed, there is a particular lack of effective treatment for primary negative 
symptoms in schizophrenia.  The human literature supports a two factor model of 
negative symptoms in which blunted affect and poverty of speech construct an expressive 
deficit domain, while anhedonia (discussed next), asociality, and avolition form an 
avolition domain (Kirkpatrick & Fischer, 2006; Liemburg et al., 2013).  Readily 
measured in animals, anhedonia and social withdrawal are the two most common 
negative symptoms modelled in animals (Ellenbroek & Cools, 2000).  NMDA receptor 
antagonism in adult rats via PCP, MK-801, or ketamine has been shown to reliably 
induce social withdrawal (Gururajan, Taylor, & Malone, 2010; Neill et al., 2010; Neill et 
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al., 2014).  To a much lesser extent, social withdrawal has also been examined in 
neurodevelopmental models with prenatal poly I:C resulting in social withdrawal in adult 
offspring mice (Smith et al., 2007) and prenatal administration of the influenza virus 
inducing social deficits (Shi et al., 2003).  Social interaction has not, to my knowledge, 
been assessed in a prenatal NMDA receptor blockade model.  We thus hypothesized that 
rats born to MK-801-treated dams would show signs of asociality in an open-field social 
interaction task.   
 Our results did not support this hypothesis, but did nonetheless give rise to an 
interesting pattern.  Although we failed to observe any statistically significant 
differences, we found that MK rats spent less time sniffing and more time wrestling the 
conspecific compared to SAL rats.  This is, to a certain extent, consistent with previous 
research showing that subchronic treatment with PCP or prenatal poly I:C administration 
results in social withdrawal in adult rodents (Gururajan et al., 2010).  However, Neill et 
al.  (2014) reports that analysis of 8 separate studies revealed that in every study 
reduction of “following” behaviour in PCP-treated rats was observed.  In the present 
study, we did not find any differences between MK and SAL rats in following behaviour.  
Nonetheless, our results appear to point towards a pattern of reduced prosocial behaviour 
in MK offspring which would merit further investigation.   
 Unfortunately, the between-subject variability in this task complicated the 
interpretation of our results.  Our procedure was not without limitations.  Similar to the 
commonly used experimental procedure described in Neill et al.  (2014), our rats were 
matched by weight, habituated to the testing environment on days prior to testing, and 
pairs of rats, unfamiliar with each other, were placed in the arena for 10 min.  Unlike this 
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procedure, however, our rats were individually caged for weeks prior to testing which 
may have affected social behaviour.  Another important feature in the social interaction 
test that was left out in our procedure is the presence of an inanimate novel object inside 
the testing arena.  This procedure allows the measurement of any differences in 
interaction of the test animal with an unfamiliar rat as opposed to an unfamiliar object 
thus allowing the researcher to make sound statements about social preference rather than 
general novelty preference (Neill et al., 2014).  Finally, in addition to measuring sniffing, 
following, mounting, and wrestling, some researchers also assess for avoidance (actively 
turning away or freezing when approached by the conspecific rat).  In addition to the 
decreased following behaviour, an increase in avoidance behaviour in PCP-treated rats 
compared to controls is commonly reported (Neill et al., 2014). 
 Although the abovementioned changes to our protocol may have led to different 
results, the open-field social interaction protocol, as described by Neill et al.  (2014), also 
has its limitations.  In this procedure, rats are always paired with another rat of the same 
treatment condition and social behaviour is based on the way in which the pair interacts.  
The assumption here is that rats of the same treatment condition will behave in similar 
ways.  The between-subject variability in our experiment suggests that this assumption is 
likely violated and that measures of social behaviour that control for such confounds 
would perhaps produce more reliable results.   One such procedure is the three-chamber 
test of sociability and preference for social novelty (Moy et al., 2004).  In the sociability 
test, the test rat is given a choice between spending time in the side with an unfamiliar rat 
(enclosed in a small wire cage allowing for nose contact between bars) versus an empty 
side.  In the test of preference for social novelty, the rat is given the choice between the 
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first unfamiliar rat and a newly introduced unfamiliar rat (Moy et al., 2004).  One may 
even wish to add a third test which would differentiate social novelty preference from 
general novelty preference by giving the test rat the choice between an unfamiliar rat and 
an unfamiliar object.   
 Effects of prenatal MK-801 on sucrose preference in adult male offspring.   A 
highly appealing feature of the NMDA receptor-blockade approach for schizophrenia 
models is that unlike AMPH challenge, which is mostly relevant to the positive 
symptoms, NMDA receptor antagonists also mimic negative symptoms such as 
anhedonia.  PCP administration in adult rats has been shown to decrease interest in 
pleasurable stimuli such as sucrose (Baird, Turgeon, Wallman, & Hulick, 2008; Turgeon 
& Hoge, 2003) and intracranial self-stimulation (Spielewoy & Markou, 2003) suggesting 
a possible anhedonic effect.  Our hypothesis that prenatal MK-801 would result in a lack 
of preference for sucrose water in adult male rats was partially supported. 
 We found that MK rats did not show preference for sucrose water, suggesting 
that, contrary to the SAL rats, they were indifferent to the sweetened water.  These results 
suggest that prenatal MK-801 induces anhedonia-like behaviours in adult offspring.  This 
anhedonia-like behaviour in MK offspring was restricted to conditions where rats were 
not water or food restricted at the time of testing.  When rats were tested under 
deprivation conditions, neither the SAL nor MK offspring showed sucrose preference.  
These results are consistent with previous work showing that rats with hippocampal 
lesions and control rats did not show sucrose preference when tested under deprivation 
conditions (T.  S.  Brown & Murphy, 1973).  When tested under non-deprivation 
conditions, however, the lesioned rats showed no preference for the sucrose solution 
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while the control rats did.  Furthermore, these findings implicate the hippocampus in the 
ability to express pleasure (T.  S.  Brown & Murphy, 1973).  Indeed, in the anhedonic 
chronic mild stress model (Grippo et al., 2005), various hippocampal changes have been 
observed.  These changes include downregulaion of cannabinoid-1 receptors and lower 
GABA levels (Gronli et al., 2007; Reich, Taylor, & McCarthy, 2009).  Thus, it is possible 
that blocking NMDA receptors during prenatal development resulted in changes in the 
hippocampus that are associated with a decreased ability to experience pleasure.   
 The literature on the role of the hippocampus in anhedonia, however, is 
inconsistent.  For instance, Jenkins et al.  (2010) found that persistent blockade of NMDA 
receptors in adult male rats resulted in reduction in the expression of parvalbumin 
immunoreactive neurons in the CA1 and CA2/3 regions of the hippocampus.  However, 
these hippocampal changes were not associated with absence of sucrose preference when 
tested with a 1% sucrose solution.  The authors conclude that although subchronic PCP 
may not serve as a valid model for anhedonia-like symptoms, it induces changes in 
hippocampal subregions that mimic pathology observed in schizophrenia.  Given that in 
the current study differences in sucrose preference were only observed when rats were 
tested with a 5% sucrose solution, one may predict that the PCP-induced changes in 
hippocampal structure would be associated with absence of sucrose preference if tested 
with a higher concentration sucrose solution.  Furthermore, in Jenkins et al.’s (2010) 
study, rats were tested for sucrose preference 1 and 2 weeks after PCP dosing ended 
while brain pathology was measured 4 weeks after the final drinking session (Jenkins, 
Harte, & Reynolds, 2010).  Thus, one cannot conclude from this study that anhedonia is 
not affected by pathology in the hippocampus.   
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 Our sucrose preference procedure was not without its limitations.  First, rats did 
not receive pre-exposure to the sucrose solution.  Such pre-exposure to the solution 
would have allowed a period of adaptation.  It is possible that our inability to show 
sucrose preference in the SAL rats under deprivation conditions (the initial test) was the 
result of novelty aversion.   
 Effects of prenatal MK-801 on set-shifting in adult male offspring.  Cognitive 
flexibility refers to the ability to shift from one learned strategy to another (i.e.  strategy 
set-shifting) or from one response pattern to another (i.e.  reversal learning), based on 
changes in environmental contingencies (Ragozzino, 2007).   Patients with schizophrenia 
display perseverative deficits on measures related to cognitive flexibility such as 
attentional set-shifting (Leeson et al., 2009; Pantelis et al., 1999) and reversal learning 
(Leeson et al., 2009; McKirdy et al., 2009; Murray et al., 2008; Pantelis et al., 1999).  
Cognitive flexibility has been assessed in several neurodevelopmental animal models of 
schizophrenia-like behaviours but has yet to be characterized in the prenatal NMDA 
receptor blockade model.  We therefore hypothesized that adult male rats born to MK-
801-treated dams would show impaired cognitive flexibility compared to SAL rats in a T-
maze set-shifting task.    
 Our hypotheses were only partially supported, but an interesting pattern of results 
emerged.  We found that MK offspring appeared to be impaired during set-shifting from 
a visual-cue strategy to an egocentric spatial strategy, or vice versa.  This was reflected in 
the apparent, but not statistically significant, differences between MK and SAL rats in 
number of trials to reach criterion during the post-shift phase.  Such an impairment 
suggests that prenatal NMDA receptor blockade disrupts normal development of the 
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circuit that has been shown to mediate strategy set-shifting which includes prefrontal 
cortical, thalamic, and striatal areas (Block, Dhanji, Thompson-Tardif, & Floresco, 2007; 
Floresco, Block, & Tse, 2008; Floresco et al., 2009; Ragozzino, 2007; Ragozzino, 
Detrick, & Kesner, 1999).  Importantly, analysis of error types in our experiment suggest 
that this apparent deficit was maintained not by perseverative errors, but by significantly 
more regressive errors in MK rats compared to SAL rats.  This finding contradicts 
previous research with various neurodevelopmental animal models of schizophrenia-like 
behaviours that have found perseveration to be responsible for impaired set-shifting.  For 
instance, neonatal ventral hippocampal lesions increase perseverative errors during 
strategy set-shifting in a T-maze task (Brady, 2009), prenatal treatment with 
methylazoxymethanol acetate impairs extra-dimensional set-shifting and reversal 
learning in an attention-based task (Featherstone, Rizos, Nobrega, Kapur, & Fletcher, 
2007), and prenatal poly I:C increases perseverative errors in a set-shifting operant-based 
task (Zhang, Cazakoff, Thai, & Howland, 2012).  Lesion to the medial PFC or thalamus 
(Block et al., 2007; Floresco et al., 2008; Ragozzino et al., 1999) as well as dopaminergic 
receptor manipulations in the mPFC (Floresco, Magyar, Ghods-Sharifi, Vexelman, & 
Tse, 2006; Ragozzino, 2002) and NAcc (Haluk & Floresco, 2009) have been shown to 
result in increased perseverative errors in set-shifting tasks.  However, as perseverative 
errors were not increased in MK offspring, it appears that these areas may have been 
spared and that our prenatal manipulation resulted in changes in other structures that are 
not necessary for the initial shift from one strategy to another.    
 In a sophisticated series of experiments reviewed in Ragozzino (2007), the 
authors examined whether the inactivation of the prelimbic cortex and the orbitofrontal 
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cortex would affect separate processes enabling cognitive flexibility.  Furthermore, 
because both these regions project to the dmSTR, the authors also examined the effects of 
dmSTR inactivation on set-shifting.  The authors showed that the prelimbic area appears 
to support cognitive flexibility in tasks where conditions require a shift in strategies or 
rules (e.g. strategy set-shifting) while the orbitofrontal cortex supports learning when the 
general strategy remains the same but a shift in specific choices is required (e.g. reversal 
learning in discrimination tests).  Notably, in contrast to prefrontal cortex subregions, 
dmSTR inactivation did not increase perseverative errors, but rather led to an increase in 
regressive errors.  This finding suggests that the dmSTR does not facilitate the initial shift 
away from a previous strategy, but it is critical for the maintenance of a new strategy.  
Therefore, it is possible that prenatal blockade of NMDA receptors resulted in changes in 
the dmSTR that would have led to increased regressive errors, while leaving the 
prelimbic cortex intact.  Given our set-shifting results and the findings described in 
Ragozzino et al.  (2007), the dmSTR may be a good place to begin the search for the 
specific neural adaptations induced by prenatal NMDA receptor blockade.  Indeed, 
researchers have shown that higher levels of NMDA receptor binding in the dmSTR were 
correlated with poorer set-shifting performance in adult male Long-Evans rats (Nicolle & 
Baxter, 2003).  Chronic prenatal MK-801administration may have resulted in increased 
glutamate release or upregulation of NMDA receptors in the dmSTR.   
In conclusion, prenatal NMDA receptor blockade resulted in impaired 
performance in a set-shifting task.  However, because the impairment was driven by 
regressive but not perseverative errors, more research is required to determine whether 
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this deficit reflects the impairment in cognitive flexibility observed in patients with 
schizophrenia.    
 Effects of prenatal MK-801 on AMPH-induced DA activity in adult male 
offspring.   Given the tenacity of the DA hypothesis in schizophrenia research, 
examining DA activity in the brains of our prenatally MK-801 treated rats is highly 
relevant.  Seeing as we failed to find differences between SAL and MK rats in sensitivity 
to the locomotor-activating effects of AMPH, which is commonly reported with animal 
models of schizophrenia-like behaviours, we chose to examine DA activity following an 
AMPH challenge.  The literature on DA activity with neurodevelopmental animal models 
of schizophrenia-like behaviours is inconsistent with researchers reporting both increases 
and decreases in DA activity depending on the model used, timing of manipulation, 
postnatal age of the offspring, and brain region examined (Boksa, 2010).  We thus 
hypothesized that we would observe differences between MK and SAL rats in DA 
activity in the NAcc, dmSTR, dlSTR, and vPFC.  Once again, this hypothesis was only 
partially supported with trends towards decreased DA turnover in the NAcc, dmSTR, and 
dlSTR. 
 Although DA activity in the prenatal NMDA receptor blockade model has yet to 
be characterized, DA activity has been examined in other neurodevelopmental animal 
models.  For instance, a large number of research groups using prenatal LPS 
administration in the rat report decreased DA levels or innervation in the NAcc or STR 
which is consistent with our results (Bakos et al., 2004; Ling et al., 2002; Romero et al., 
2010; Snyder-Keller & Stark, 2008).  On the other hand, other researchers using this 
same model have reported increased DA levels and tyrosine hydroxylase (TH; rate-
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limiting enzyme in DA synthesis) immunoreactivity in the NAcc (Borrell, Vela, Arevalo-
Martin, Molina-Holgado, & Guaza, 2002; Romero et al., 2007; Romero et al., 2010).  
Research with prenatal poly I:C appears to provide more evidence for increased DA 
activity in the offspring.  For instance, researchers have shown increased KCl-induced 
DA release from striatal slices prepared from rat offspring born to poly I:C-treated dams 
(Zuckerman et al., 2003) and increased TH immunoreactivity in the NAcc and STR and 
increased levels of DA in the PFC of adult poly I:C mice (Meyer, Engler, Weber, 
Schedlowski, & Feldon, 2008; Meyer, Nyffeler, Schwendener, et al., 2008; Meyer, 
Nyffeler, Yee, et al., 2008; Winter et al., 2009).  Others have reported increased DA 
turnover in the STR of adult mice prenatally treated with poly I:C from GD 12 to 17 
(Ozawa et al., 2006). 
 Due to unfortunate technical complications with our HPLC procedure and the 
absence of statistically significant results, we cannot confidently state that MK rats do in 
fact exhibit reduced DA activity.  Nonetheless, these results are interesting as they 
corroborate some of our behavioural observations.  More specifically, reduced DA 
activity following an AMPH challenge may explain why we failed to see differences in 
AMPH-induced locomotor activity and reduced sensitivity to the locomotor-activating 
effects of MK-801.  Furthermore, reduced DA turnover in the dmSTR, an area shown to  
be critical for the maintenance of a new strategy (Ragozzino, 2007), may help explain 
why MK rats made significantly more regressive errors than SAL rats in our set-shifting 
task.    
 Concluding remarks.  Results from this extensive project do not support the 
general hypothesis that prenatal MK-801 administration results in schizophrenia-like 
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behaviour in adult offspring.  However, it should be clear to the reader that our prenatal 
manipulation did in fact induce changes in offspring neurodevelopment that gave rise to 
behavioural, and possibly neurochemical, alterations in the adult offspring.  Although our 
findings were sometimes in the opposite of our hypotheses and further research will be 
required to determine the exact nature of these alterations, we feel that the results are 
interesting in their own right and contribute to the advancement of our understanding of 
the role of NMDA receptors in development and behaviour.   
 We hope that future studies will expand on our findings with molecular 
techniques that would help elucidate the changes observed in our animals.  An important 
future direction would be to examine the potential compensatory mechanisms that 
emerged as a result of NMDA receptor blockade.  One promising direction is suggested 
by Lu et al.  (2011), who identified changes in glutamate levels and expression of glial 
glutamate transporters in prenatal PCP offspring.  Another important avenue would be 
replicate and expand on the findings of Abekawa et al.  (2007) who found that prenatal 
MK-801 administration disrupted GABAergic neurodevelopment in the mPFC of rat 
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